<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">BMC Psychiatry</journal-id><journal-id journal-id-type="pmc-domain-id">62</journal-id><journal-id journal-id-type="pmc-domain">bmcpsyc</journal-id><journal-title-group><journal-title>BMC Psychiatry</journal-title></journal-title-group><issn pub-type="epub">1471-244X</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11816523</article-id><article-id pub-id-type="pmcid-ver">PMC11816523.1</article-id><article-id pub-id-type="pmcaid">11816523</article-id><article-id pub-id-type="pmcaiid">11816523</article-id><article-id pub-id-type="pmid">39934692</article-id><article-id pub-id-type="doi">10.1186/s12888-024-06461-0</article-id><article-id pub-id-type="publisher-id">6461</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Psychiatric disorders and following risk of chronic kidney disease: a prospective cohort study from UK Biobank</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Li</surname><given-names initials="H">Hanfei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Li</surname><given-names initials="C">Chunyang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="C">Chao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ying</surname><given-names initials="Z">Zhiye</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="C">Chuanfang</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zeng</surname><given-names initials="X">Xiaoxi</given-names></name><address><email>zengxiaoxi@wchscu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Bao</surname><given-names initials="J">Jinku</given-names></name><address><email>baojinku@scu.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/011ashp19</institution-id><institution-id institution-id-type="GRID">grid.13291.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 0807 1581</institution-id><institution>Division of Nephrology and West China Biomedical Big Data Center, West China Hospital, </institution><institution>Sichuan University, </institution></institution-wrap>Chengdu, 610041 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/011ashp19</institution-id><institution-id institution-id-type="GRID">grid.13291.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 0807 1581</institution-id><institution>College of Life Science, </institution><institution>SiChuan University, </institution></institution-wrap>Chengdu, 610064 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/011ashp19</institution-id><institution-id institution-id-type="GRID">grid.13291.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 0807 1581</institution-id><institution>Med-X Center for Informatics, </institution><institution>Sichuan University, </institution></institution-wrap>Chengdu, 610065 China </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><issue-id pub-id-type="pmc-issue-id">478311</issue-id><elocation-id>109</elocation-id><history><date date-type="received"><day>17</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>27</day><month>12</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>12</day><month>02</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-02-15 07:25:24.907"><day>15</day><month>02</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12888_2024_Article_6461.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Psychiatric disorders have been reported to influence many health outcomes, but evidence about their impact on chronic kidney disease (CKD) has not been fully explored, as well as possible mechanisms implicated are still unclear.</p></sec><sec><title>Methods</title><p id="Par2">Four hundred forty-one thousand eight hundred ninety-three participants from UK Biobank were included in this study. To assess the association between psychiatric disorders mainly including depression, anxiety, stress-related disorders, substance misuse as well as psychotic disorder, and CKD, a Cox regression model using age as the underlying time scale was employed. This approach considers the age progression of participants from the beginning to the end of the study as the elapsed time. Flexible nonparametric smoothing model was conducted to illustrate the temporal patterns. Subgroup analyses were performed by stratification of gender, genetic susceptibility to CKD, age at entry or exit the cohort, follow-up duration, and the number of psychiatric disorders at baseline. Mediation analysis was implemented to evaluate the roles of body mass index (BMI), hypertension, and diabetes.</p></sec><sec><title>Results</title><p id="Par3">Compared with individuals without psychiatric disorders, an increased risk of CKD was observed in patients with psychiatric disorders (hazard ratios (HR)&#8201;=&#8201;1.52, 95% confidence intervals (CI): 1.40&#8211;1.65, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001). The hazard ratio among psychiatric patients gradually increased, and became significant after about 10 years follow-ups. The HR for patients followed up for 10&#8211;12 years was 1.60 (95% CI: 1.34&#8211;1.91, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001), and the HR was 1.66 (95% CI: 1.29&#8211;2.13, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001) for patients followed up for 12&#8211;13 years. Five distinct psychiatric disorders were found to be significantly associated with an increased risk of developing CKD. The highest HR was observed between stress-related disorder and CKD (HR&#8201;=&#8201;1.95, 95%CI: 1.28&#8211;2.97, <italic toggle="yes">p</italic>-value&#8201;=&#8201;0.002). When adjusting genetic susceptibility to CKD, the HR for the association between stress-related disorders and CKD became 1.86 (95%CI: 1.14&#8211;3.04, <italic toggle="yes">p</italic>-value&#8201;=&#8201;0.013). Although these associations were nominally significant, they did not reach statistical significance after applying the Bonferroni multiple corrections, potentially due to the limited sample size. Subgroup analysis revealed that psychiatric patients who are under age 60, with multiple psychiatric morbidities or having been diagnosed with psychiatric disorders for over 10 years may be high-risk populations. Hypertension, BMI and diabetes mediated 49.13% (95% CI: 37.60%-67.08%), 12.11% (95% CI: 8.49%-17.24%) and 3.78% (95% CI: 1.58%-6.52%) of the total effect, respectively.</p></sec><sec><title>Conclusions</title><p id="Par4">Psychiatric disorders were associated with a delayed onset of an elevated risk for CKD, this association was only observed in patients with psychiatric disorders for more than 10 years. Our study highlights the significance of lifestyle interventions, routine monitoring of kidney function, early screening for CKD, and personalized management strategies for psychiatric patients as potential approaches to the precise prevention of CKD.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12888-024-06461-0.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Psychiatric disorders</kwd><kwd>Chronic kidney diseases</kwd><kwd>Age as time scale</kwd><kwd>Mediation analysis</kwd></kwd-group><funding-group><award-group><funding-source><institution>Key Research and Development Program of Chengdu</institution></funding-source><award-id>2021-YF08-00167-GX</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>the 1&#8226;3&#8226;5 project for disciplines of ex-cellence, West China Hospital, Sichuan University</institution></funding-source><award-id>ZYJC18010</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>Digital Economy Pilot Project for Application of Healthcare Big Data from National Development and Reform Commission of China</institution></funding-source><award-id>2018gfgw001</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Chronic kidney disease (CKD) is a long-term condition that is growing in prevalence, yet receives limited recognition. According to the statistics from the Global Burden of Disease, approximately one-tenth of the world&#8217;s population was affected by CKD, which caused 1.5 million deaths [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Due to a lack of symptoms, early-stage CKD is often hard to detect [<xref ref-type="bibr" rid="CR3">3</xref>]. CKD can progress to end-stage renal disease (ESRD), between 2001 and 2019, the number of patients with newly registered ESRD increased by 37.8% in the U.S. [<xref ref-type="bibr" rid="CR4">4</xref>], leading to significant social and economic burdens [<xref ref-type="bibr" rid="CR5">5</xref>]. Many people are diagnosed at the end stage, requiring kidney replacement therapy to stay alive, which burdens both patients and the healthcare system [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, identifying risk factors of CKD is crucial in reducing CKD incidence.
</p><p id="Par6">Psychiatric disorders may last for a long time and impact many health outcomes throughout life. Psychiatric disorders are not only associated with some neuropsychiatric disorders like dementia [<xref ref-type="bibr" rid="CR8">8</xref>], Parkinson&#8217;s disease [<xref ref-type="bibr" rid="CR9">9</xref>] and Alzheimer&#8217;s disease [<xref ref-type="bibr" rid="CR10">10</xref>], but also many somatic diseases, for example, hypertension [<xref ref-type="bibr" rid="CR11">11</xref>], diabetes [<xref ref-type="bibr" rid="CR12">12</xref>], cardiovascular diseases [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], heart failure [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], autoimmune disease [<xref ref-type="bibr" rid="CR17">17</xref>], infection [<xref ref-type="bibr" rid="CR18">18</xref>] and cancer [<xref ref-type="bibr" rid="CR19">19</xref>]. One study focusing on the disease trajectories following psychiatric disorders found the trajectory from depression to CKD [<xref ref-type="bibr" rid="CR20">20</xref>]. Patients with CKD or ESRD usually comorbid with more prevalent comorbid psychiatric conditions, which can affect mental health in turn [<xref ref-type="bibr" rid="CR21">21</xref>]. However, the effects of multiple types of clinically confirmed psychiatric disorders on the following risk of CKD have not been fully explored using longitudinal data, as well as possible mechanisms involved in the association are still unclear.</p><p id="Par7">Using the population-based longitudinal data from the UK Biobank, we assessed the effects of psychiatric disorders, primarily including depression, anxiety, stress-related disorder, substance misuse as well as psychotic disorders on the risk of subsequent CKD. We also evaluated the impact of age, gender, follow-up time, number of psychiatric disorders and genetic predisposition on this association. Mediation analyses were performed to elucidate the possible mechanisms linking psychiatric disorders and CKD.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study population</title><p id="Par8">This study assessed the association between psychiatric disorders and CKD using data from the UK Biobank cohort study. The UK Biobank is a large population-based prospective cohort study that recruited approximately 500,000 middle-aged (40&#8211;69&#160;years) participants from England, Scotland and Wales. Baseline data from the UK Biobank was collected between 2006 and 2010 in 22 research assessment centers across the UK. With the consent of participants, health-related outcomes were obtained periodically from external healthcare providers. Hospital inpatient records were linked to Hospital Episode Statistics (HES) for England, Scottish Morbidity Record for Scotland, and Patient Episode Database for Wales, Nationwide mortality data were derived from the National Health Service (NHS) Digital for England and Wales, as well as NHS Central Register for Scotland [<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec4"><title>Study design</title><p id="Par9">In the present study, among 502,507 participants, we excluded participants based on the following criteria: (1) withdrew their consent form (N&#8201;=&#8201;194); (2) with any congenital CKD proceeding the baseline (N&#8201;=&#8201;8,595); (3) diagnosed CKD before the start of follow-up (90&#160;days after the date of recruitment, N&#8201;=&#8201;2,619); (4) with estimated glomerular filtration rate (eGFR)&#8201;&lt;&#8201;60&#160;mL &#183;min<sup>&#8722;1</sup> 1.73&#160;m<sup>&#8722;2</sup> based on eGFR<sub>create</sub> or missing values on eGFR<sub>create</sub> (N&#8201;=&#8201;49,101) at the recruitment between 2006 to 2010; and (5) died before the start of follow up (N&#8201;=&#8201;105). Finally, 441,893 participants were included in the final primary analytic cohort (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Flowchart of study population. CKD: Chronic kidney disease; QC: Quality control</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12888_2024_6461_Fig1_HTML.jpg"/></fig></p><p id="Par10">In order to explore the influence of genetic predisposition on the association between psychiatric disorders and CKD, we derived a genetic cohort by further excluding participants based on the following criteria: (1) non-Caucasian (N&#8201;=&#8201;23,609); (2) did not pass the quality control of genetic data (i.e., with in-consistent self-reported and genetic sex, or high rates of genotype missingness and heterozygosity; N&#8201;=&#8201;105,318); and (3) with first or second level of relatedness (i.e., with the kinship coefficient&#8201;&gt;&#8201;0.0884; N&#8201;=&#8201;15,179) [<xref ref-type="bibr" rid="CR23">23</xref>]. Finally, 297,787 participants were included in the final genetic analytic cohort. The flowchart representing the selection of study population was shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>. The characteristics of participants with or without psychiatric disorders were presented and compared using t test or chi-squared test, as appropriate.</p></sec><sec id="Sec5"><title>Ascertainment of exposure</title><p id="Par11">We retrieved diagnosis information of depression, anxiety, stress-related disorder, substance misuse, and psychotic disorders using ICD-9 and ICD-10 codes from UK Biobank inpatient records (codes were listed in Additional File 1: Supplementary Table S1) [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Psychiatric disorders at the baseline were defined as any of 5 diseases as mentioned above. If an individual had received more than one diagnosis of the same psychiatric disorder prior to the baseline, we included the date of the initial diagnosis for each of the five psychiatric disorders in our analyses.</p></sec><sec id="Sec6"><title>Ascertainment of outcomes</title><p id="Par12">CKD outcomes were identified as follows: (1) first diagnosis of incident chronic renal failure, initiation of renal replacement therapy, development of renal complications of hypertension or diabetes, glomerular diseases, or other renal structural abnormality after 90&#160;days of the recruitment date (ICD-10 codes were listed in Additional File 1: Supplementary Table S2); (2) presenting with decreased kidney function, defined by urine albumin/creatinine ratio&#8201;&#8805;&#8201;30&#160;mg/g, or eGFR&#8201;&lt;&#8201;60&#160;mL &#183;min<sup>&#8722;1</sup> 1.73&#160;m<sup>&#8722;2</sup> based on eGFR<sub>creat</sub> or eGFR<sub>creat&#8722;cys</sub> as appropriate [<xref ref-type="bibr" rid="CR26">26</xref>], at the repeated assessment during follow-up from 2012 to 2013. The timing of event was recorded by the first diagnosis date of CKD incidence, or 31 December 2012, which was the timing for ascertaining incident CKD by abnormal laboratory tests. As the diagnosis of CKD is based on persistent kidney impairment for at least three months, we used a time interval of 90&#160;days from the date of recruitment to define the CKD outcome [<xref ref-type="bibr" rid="CR26">26</xref>]. The end of follow-up was the date of first CKD diagnosis, the date of death, or the end of follow up (31 August 2021) whichever came first.</p></sec><sec id="Sec7"><title>Ascertainment of covariates</title><p id="Par13">Covariates included sex [<xref ref-type="bibr" rid="CR27">27</xref>], ethnicity [<xref ref-type="bibr" rid="CR28">28</xref>], education level [<xref ref-type="bibr" rid="CR29">29</xref>], annual household income level [<xref ref-type="bibr" rid="CR30">30</xref>], Townsend deprivation index [<xref ref-type="bibr" rid="CR31">31</xref>], diet including tea intake, vegetable intake, processed meat intake and unprocessed meat [<xref ref-type="bibr" rid="CR32">32</xref>], physical activity level and body mass index (BMI) [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] collected at baseline, and age, hypertension [<xref ref-type="bibr" rid="CR34">34</xref>], diabetes [<xref ref-type="bibr" rid="CR35">35</xref>] and Charlson comorbidity index [<xref ref-type="bibr" rid="CR36">36</xref>] collected until November 2016. Data fields and questionnaires used to define the covariates were listed in Additional File 1: Supplementary Table S3. Charlson Comorbidity index (CCI) at baseline, an indicative of baseline comorbidity level, was calculated using diagnoses of the UK Biobank inpatient hospital records as described previously (the definition of CCI was described in Additional File 1: Supplementary Table S4), and categorized in 5 classes, 0, 1&#8211;2, 3&#8211;4 and&#8201;&#8805;&#8201;5 [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Ethnicity was divided into White, Asian, Black, mixed and others reported by participants. Education level was categorized into one category of A levels /AS levels /O levels /GCSEs / GSEs or equivalent, one category of college or university degree, and one category of other qualifications [<xref ref-type="bibr" rid="CR39">39</xref>]. Townsend deprivation index was quantified according to the postal code of participants. Annual household income was divided into ultra-high (&gt;&#8201;&#8356;100,000), high (&#8356;52,000 to &#8356;100,000), medium (&#8356;31,000 to &#8356;51,999), low (&#8356;18,000 to &#8356;30,999) and ultra-low (&lt;&#8201;&#8356;18,000) levels and ultra-low levels. BMI was categorized into obese (&#8805;&#8201;30kg/m<sup>2</sup>), overweight (25&#8211;30 kg/m<sup>2</sup>), normal (&#8804;&#8201;30kg/m<sup>2</sup>) and unknown. Physical activity was defined as low level (&lt;&#8201;10 h moderate to vigorous physical activities per week), moderate level (10&#8211;50 h moderate to vigorous physical activities per week), high level (&#8805;&#8201;50 h moderate to vigorous physical activities per week) [<xref ref-type="bibr" rid="CR40">40</xref>] and unknown. Deity factors included unprocessed meat intake (classified into&#8201;&lt;&#8201;1, 1&#8211;2,&#8201;&gt;&#8201;2 times per week or unknown), processed meat intake (never,&#8201;&lt;&#8201;1, 1,&#8201;&#8805;&#8201;2 times per week or unknown), vegetables intake (&lt;&#8201;2, 2&#8211;3, 3&#8211;4,&#8201;&#8805;&#8201;4 servings per day or unknown) and tea intake (nondrinker,&#8201;&lt;&#8201;2, 2&#8211;3,&#8201;&gt;&#8201;3 cups per day or unknown). The missing value were coded as an &#8220;unknown&#8221; category for all the categorical variables [<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="Sec8"><title>Polygenetic risk score of CKD</title><p id="Par14">Genotyping in the UK Biobank was performed using the UK BiLEVE Axiom<italic toggle="yes">&#8482;</italic> Array and UK Biobank Axiom array from Affymetrix, and variants were imputed using Haplotype Reference Consortium, as well as merging UK10K and 1000 Genomes phase 3 reference panels. In this study, a recent genome-wide association study of eGFR based on serum creatinine of CKD Genetics (CKDGen) Consortium was used as the base data [<xref ref-type="bibr" rid="CR41">41</xref>], and the Polygenetic risk score (PRS) was calculated using PLINK 1.9 (details were described in Additional File 1: Supplementary Methods).</p></sec><sec id="Sec9"><title>Statistical analysis</title><p id="Par15">The proportional hazard (PH) assumption of the Cox regression model was firstly tested using &#8220;cox.zph&#8221; function in &#8220;survival&#8221; package (version 3.5.5). The cumulative incidence curves were plotted for individuals with and without psychiatric disorders to visually assess whether the PH assumption might be violated [<xref ref-type="bibr" rid="CR42">42</xref>]. To evaluate the effects of psychiatric disorders on the subsequent risk of developing CKD, Cox regression model was employed, utilizing age as the underlying time scale. This approach considers the age progression of participants from the start of the study to the end of the study as time elapsed and could better account for the left-censoring of the participants compared to conventional methods [<xref ref-type="bibr" rid="CR43">43</xref>]. Model was adjusted for sex (female or male), ethnicity (Asian, Black, mixed, White or other), social economic factors including Townsend deprivation index (in quantile), annual household income (ultralow, low, medium, high, ultrahigh or unknown), the education level (college or university degree, A levels/ AS levels/ O levels/ GCSEs/ CSEs or equivalent, other degree, or unknown), lifestyle factors including physical activity (low, moderate, high levels or unknown), unprocessed meat intake (&lt;&#8201;1, 1&#8211;2, or 2 times per week or unknown), processed meat intake (never,&#8201;&lt;&#8201;1, 1,&#8201;&#8805;&#8201;2 times per week or unknown), vegetable intake (&lt;&#8201;2, 2&#8211;3, 3&#8211;4,&#8201;&#8805;&#8201;4 servings per day or unknown),tea intake (nondrinker,&#8201;&lt;&#8201;2, 2&#8211;3,&#8201;&gt;&#8201;3 cups per day or unknown), BMI (normal, overweight, obese or unknown), the CCI (0, 1&#8211;2, 3&#8211;4, or&#8201;&#8805;&#8201;5), hypertension and diabetes at baseline (yes or no) or genetic risk of CKD (in tertile).</p><p id="Par16">The separate effects of 5 different psychiatric disorders at baseline (depression, anxiety, stress-related disorder, substance misuse and psychotic disorders) on the risk of developing CKD were also evaluated using Cox regression model with age as underlying time scale adjusting for all above-mentioned covariates. A flexible nonparametric smoothing model was employed to illustrate the temporal pattern of the association between psychiatric disorders and following risk of CKD, using &#8220;bshazard&#8221; function in &#8220;bshazard&#8221; package (version 1.1) [<xref ref-type="bibr" rid="CR44">44</xref>].</p><p id="Par17">In subgroup analyses, we calculated the HRs by age at entry into the cohort (&lt;&#8201;50, 50&#8211;60, or&#8201;&#8805;&#8201;60&#160;years), age at exit from the cohort (&#8804;&#8201;70 or&#8201;&gt;&#8201;70), gender (female or male), follow up time (0&#8211;5, 5&#8211;10, 10&#8211;12, 12&#8211;13, or&#8201;&#8805;&#8201;13&#160;years), the number of psychiatric disorders (1, 2, or&#8201;&#8805;&#8201;3) and genetic risk for CKD (in tertile of low, medium, high). The potential differential effects were tested using likelihood-ratio test comparing the models with and without the interaction terms (between the exposure of psychiatric disorders and above-mentioned variables including age at entry or exit from the cohort, gender, follow up time, the number of psychiatric disorders at baseline and genetic risk for CKD).</p></sec><sec id="Sec10"><title>Sensitivity analysis</title><p id="Par18">To further test the robustness of the results, we (1) removed CKD cases diagnosed within the first 1, 2, and 5&#160;years after recruitment to further reduce the likelihood of reverse causality and calculated HRs, (2) excluding outliers of BMI (&lt;&#8201;16.5 kg/m<sup>2</sup> or&#8201;&gt;&#8201;40 kg/m<sup>2</sup>) [<xref ref-type="bibr" rid="CR45">45</xref>] and calculated HRs, (3) the Fine and Gray competing risk model was used to estimate subdistribution hazard ratios using &#8220;crr&#8221; function in &#8220;cmprsk&#8221; package, considering all-cause death and CKD death (recorded as: cause of death of CKD, which was coded as &#8220;N18&#8221; in death registry) as the competing risk, respectively.</p></sec><sec id="Sec11"><title>Mediation analysis</title><p id="Par19">Considering that BMI, hypertension and diabetes are the potential risk factors for both CKD and psychiatric disorders, mediation analyses were individually conducted to decompose the total effect of psychiatry disorders on CKD that is mediated by BMI, hypertension and diabetes using the &#8220;mediate&#8221; function in the &#8220;mediation&#8221; package (version 4.5.0) [<xref ref-type="bibr" rid="CR46">46</xref>]. Mediation analysis allowed for quantification of direct effects (the association of psychiatric disorders with CKD that is not mediated by these factors), indirect effect (the association of psychiatric disorders with CKD that is mediated by these factors) and total effect (direct and indirect effects).</p><p id="Par20">Briefly, mediators of BMI (continuous), hypertension and diabetes (yes or no) were individually regressed on exposure (psychiatric disorders) and confounders (sex, ethnicity, Townsend deprivation index, physical activity, unprocessed meat intake, vegetable intake, processed meat intake, tea intake, CCI) using logistic or linear regression as appropriate. Subsequently, the outcome (CKD) was regressed on each mediator (BMI, hypertension or disbetes), exposure (psychiatric disorders), and above-mentioned confounders. No interaction was considered between exposure and mediators or between mediators and mediators. Point estimates and confidence intervals (CIs) were estimated using the quasi-Bayesian Monte Carlo approximation method, 95% CIs were obtained by bootstrap estimation with 1000 boots [<xref ref-type="bibr" rid="CR46">46</xref>].</p><p id="Par21">For analyzing the effect of any psychiatric disorders at baseline on risk of CKD, a 2-sided <italic toggle="yes">P</italic>-value&#8201;&lt;&#8201;0.05 was considered statistically significant. For 5 different psychiatric disorders of depression, anxiety, stress-related disorder, substance misuse and psychotic disorders, a <italic toggle="yes">P</italic>-value&#8201;&lt;&#8201;Bonferroni multiple correction (0.05/5&#8201;=&#8201;0.01) was considered statistically significant. All analyses were conducted using R (version 4.1.2).</p></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>Cohort characteristics</title><p id="Par22">Among 441,893 UK Biobank participants enrolled in the current study, the median age was 57.97 years (median IQR: 50.32&#8211;63.47), 54.51% were females. We identified a total of 8,308 participants with psychiatric disorders at the baseline recruitment (including 3,932 for depression, 1,460 for anxiety, 328 for stress-related disorder, 3,309 for substance misuse and 613 for psychotic disorders, see in Additional File 1: Supplementary Table S5). As shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, 3,029 (36.46%) patients with psychiatric disorder were under age 53, while the number in individuals without psychiatric disorders was 143,549 (33.11%). In general, compared with individuals without psychiatric disorders, patients with psychiatric disorder were more likely to be male, younger, obese, much more comorbidity, and have history of hypertension or diabetes (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Patients with psychiatric disorders also tended to have a lower level of education, annual household income and physical activity, as well as less consumptions of tea, vegetables and unprocessed meat and more processed meat intake (p&#8201;&lt;&#8201;0.001). With a median follow-up duration of 12.18 years, 17,287 cases (3.91%) of CKD were observed after 90 days from the baseline. Among patients with psychiatric disorders, 638 (7.68%) developed CKD, whereas the number of participants without psychiatric disorders who developed CKD was 16,649 (3.84%).
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Characteristics of the study cohort in primary analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variables</th><th align="left" colspan="1" rowspan="1">Total (<italic toggle="yes">N</italic>&#8201;=&#8201;441,893)</th><th align="left" colspan="1" rowspan="1">Individuals without psychiatric disorders (<italic toggle="yes">N</italic>&#8201;=&#8201;433,585)</th><th align="left" colspan="1" rowspan="1">Individuals with psychiatric disorders (<italic toggle="yes">N</italic>&#8201;=&#8201;8308)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p-</italic>value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><bold>Sex</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Women</td><td align="left" colspan="1" rowspan="1">240,873 (54.51%)</td><td align="left" colspan="1" rowspan="1">236,953 (54.65%)</td><td align="left" colspan="1" rowspan="1">3920 (47.18%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Men</td><td align="left" colspan="1" rowspan="1">201,020 (45.49%)</td><td align="left" colspan="1" rowspan="1">196,632 (45.35%)</td><td align="left" colspan="1" rowspan="1">4388 (52.82%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Baseline age, median [IQR]</bold></td><td align="left" colspan="1" rowspan="1">57.97 [50.32, 63.47]</td><td align="left" colspan="1" rowspan="1">57.99 [50.33, 63.48]</td><td align="left" colspan="1" rowspan="1">56.77 [49.69, 62.55]</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>Baseline age</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;&#8201;53</td><td align="left" colspan="1" rowspan="1">146,578 (33.17%)</td><td align="left" colspan="1" rowspan="1">143,549 (33.11%)</td><td align="left" colspan="1" rowspan="1">3029 (36.46%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;53&#8211;61</td><td align="left" colspan="1" rowspan="1">130,301 (29.49%)</td><td align="left" colspan="1" rowspan="1">127,718 (29.46%)</td><td align="left" colspan="1" rowspan="1">2583 (31.09%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&gt;&#8201;61</td><td align="left" colspan="1" rowspan="1">165,014 (37.34%)</td><td align="left" colspan="1" rowspan="1">162,318 (37.44%)</td><td align="left" colspan="1" rowspan="1">2696 (32.45%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1"><bold>Ethnicity</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;White</td><td align="left" colspan="1" rowspan="1">418,284 (94.66%)</td><td align="left" colspan="1" rowspan="1">410,424 (94.66%)</td><td align="left" colspan="1" rowspan="1">7860 (94.61%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Asian</td><td align="left" colspan="1" rowspan="1">10,032 (2.27%)</td><td align="left" colspan="1" rowspan="1">9877 (2.28%)</td><td align="left" colspan="1" rowspan="1">155 (1.87%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Black</td><td align="left" colspan="1" rowspan="1">6992 (1.58%)</td><td align="left" colspan="1" rowspan="1">6872 (1.58%)</td><td align="left" colspan="1" rowspan="1">120 (1.44%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Mixed</td><td align="left" colspan="1" rowspan="1">2630 (0.60%)</td><td align="left" colspan="1" rowspan="1">2549 (0.59%)</td><td align="left" colspan="1" rowspan="1">81 (0.97%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Other</td><td align="left" colspan="1" rowspan="1">3955 (0.90%)</td><td align="left" colspan="1" rowspan="1">3863 (0.89%)</td><td align="left" colspan="1" rowspan="1">92 (1.11%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Townsend deprivation index, median [IQR]</bold></td><td align="left" colspan="1" rowspan="1">&#8722;2.16 [&#8722;3.66, &#8722;0.49]</td><td align="left" colspan="1" rowspan="1">&#8722;2.18 [&#8722;3.67, &#8722;0.42]</td><td align="left" colspan="1" rowspan="1">0.27 [&#8722;2.58, &#8722;3.61]</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Townsend quintile</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;<bold>1</bold></td><td align="left" colspan="1" rowspan="1">110,474 (25.00%)</td><td align="left" colspan="1" rowspan="1">109,360 (25.22%)</td><td align="left" colspan="1" rowspan="1">1114 (13.41%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;<bold>2</bold></td><td align="left" colspan="1" rowspan="1">110,473 (25.00%)</td><td align="left" colspan="1" rowspan="1">109,158 (25.18%)</td><td align="left" colspan="1" rowspan="1">1315 (15.83%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;<bold>3</bold></td><td align="left" colspan="1" rowspan="1">110,476 (25.00%)</td><td align="left" colspan="1" rowspan="1">108,641 (25.06%)</td><td align="left" colspan="1" rowspan="1">1835 (22.09%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;<bold>4</bold></td><td align="left" colspan="1" rowspan="1">110,470 (25.00%)</td><td align="left" colspan="1" rowspan="1">106,426 (24.55%)</td><td align="left" colspan="1" rowspan="1">4044 (48.68%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Educational level</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;A levels /AS levels /O levels /GCSEs / GSEs or equivalent</td><td align="left" colspan="1" rowspan="1">167,640 (37.94%)</td><td align="left" colspan="1" rowspan="1">164,548 (37.95%)</td><td align="left" colspan="1" rowspan="1">3092 (37.22%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;College or university degree</td><td align="left" colspan="1" rowspan="1">145,215 (32.86%)</td><td align="left" colspan="1" rowspan="1">143,445 (33.08%)</td><td align="left" colspan="1" rowspan="1">1770 (21.30%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Other qualifications</td><td align="left" colspan="1" rowspan="1">51,464 (11.65%)</td><td align="left" colspan="1" rowspan="1">50,464 (11.64%)</td><td align="left" colspan="1" rowspan="1">1000 (12.04%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" colspan="1" rowspan="1">77,574 (17.55%)</td><td align="left" colspan="1" rowspan="1">75,128 (17.33%)</td><td align="left" colspan="1" rowspan="1">2446 (29.44%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Charlson Comorbidity index</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;0</td><td align="left" colspan="1" rowspan="1">389,909 (88.24%)</td><td align="left" colspan="1" rowspan="1">384,854 (88.76%)</td><td align="left" colspan="1" rowspan="1">5055 (60.84%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;1&#8211;2</td><td align="left" colspan="1" rowspan="1">45,312 (10.25%)</td><td align="left" colspan="1" rowspan="1">42,722 (9.85%)</td><td align="left" colspan="1" rowspan="1">2590 (31.17%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;3&#8211;4</td><td align="left" colspan="1" rowspan="1">3990 (0.90%)</td><td align="left" colspan="1" rowspan="1">3525 (0.81%)</td><td align="left" colspan="1" rowspan="1">465 (5.60%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;&#8201;5</td><td align="left" colspan="1" rowspan="1">2682 (0.61%)</td><td align="left" colspan="1" rowspan="1">2484 (0.57%)</td><td align="left" colspan="1" rowspan="1">198 (2.38%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Annual household income level</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Ultralow (&lt;&#8201;&#8356;18,000)</td><td align="left" colspan="1" rowspan="1">83,637 (18.93%)</td><td align="left" colspan="1" rowspan="1">80,171 (18.49%)</td><td align="left" colspan="1" rowspan="1">3466 (41.72%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Low (&#8356;18,000 to &#8356;30,999)</td><td align="left" colspan="1" rowspan="1">95,695 (21.66%)</td><td align="left" colspan="1" rowspan="1">94,135 (21.71%)</td><td align="left" colspan="1" rowspan="1">1560 (18.78%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Medium (&#8356;31,000 to &#8356;51,999)</td><td align="left" colspan="1" rowspan="1">100,011 (22.63%)</td><td align="left" colspan="1" rowspan="1">98,951 (22.82%)</td><td align="left" colspan="1" rowspan="1">1060 (12.76%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;High (&#8356;52,000 to &#8356;100,000)</td><td align="left" colspan="1" rowspan="1">78,858 (17.85%)</td><td align="left" colspan="1" rowspan="1">78,270 (18.05%)</td><td align="left" colspan="1" rowspan="1">588 (7.08%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Ultrahigh (&gt;&#8201;&#8356;100,000)</td><td align="left" colspan="1" rowspan="1">21,075 (4.77%)</td><td align="left" colspan="1" rowspan="1">20,990 (4.84%)</td><td align="left" colspan="1" rowspan="1">85 (1.02%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" colspan="1" rowspan="1">62,617 (14.17%)</td><td align="left" colspan="1" rowspan="1">61,068 (14.08%)</td><td align="left" colspan="1" rowspan="1">1549 (18.64%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Body mass index</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Normal (&#8804;&#8201;25&#160;kg/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">148,309 (33.56%)</td><td align="left" colspan="1" rowspan="1">146,005 (33.67%)</td><td align="left" colspan="1" rowspan="1">2304 (27.73%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Overweight (25&#8211;30&#160;kg/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">187,269 (42.38%)</td><td align="left" colspan="1" rowspan="1">184,154 (42.47%)</td><td align="left" colspan="1" rowspan="1">3115 (37.49%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Obese (&#8805;&#8201;30&#160;kg/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">104,662 (23.68%)</td><td align="left" colspan="1" rowspan="1">101,862 (23.49%)</td><td align="left" colspan="1" rowspan="1">2800 (33.70%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" colspan="1" rowspan="1">1653 (0.37%)</td><td align="left" colspan="1" rowspan="1">1564 (0.36%)</td><td align="left" colspan="1" rowspan="1">89 (1.07%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Hypertension at baseline</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">410,773 (92.96%)</td><td align="left" colspan="1" rowspan="1">404,489 (93.29%)</td><td align="left" colspan="1" rowspan="1">6284 (75.64%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">31,120 (7.04%)</td><td align="left" colspan="1" rowspan="1">29,096 (6.71%)</td><td align="left" colspan="1" rowspan="1">2024 (24.36%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Diabetes at baseline</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">433,529 (98.11%)</td><td align="left" colspan="1" rowspan="1">425,815 (98.21%)</td><td align="left" colspan="1" rowspan="1">7714 (92.85%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">8364 (1.89%)</td><td align="left" colspan="1" rowspan="1">7770 (1.79%)</td><td align="left" colspan="1" rowspan="1">594 (7.15%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Physical activity level</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Low (&lt;&#8201;10&#160;h moderate and vigorous activities per week)</td><td align="left" colspan="1" rowspan="1">140,883 (31.88%)</td><td align="left" colspan="1" rowspan="1">137,743 (31.77%)</td><td align="left" colspan="1" rowspan="1">3140 (37.79%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Moderate (10&#8211;50&#160;h moderate and vigorous activities per week)</td><td align="left" colspan="1" rowspan="1">155,908 (35.28%)</td><td align="left" colspan="1" rowspan="1">153,720 (35.45%)</td><td align="left" colspan="1" rowspan="1">2188 (26.34%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;High (&#8805;&#8201;50&#160;h moderate and vigorous activities per week)</td><td align="left" colspan="1" rowspan="1">61,602 (13.94%)</td><td align="left" colspan="1" rowspan="1">60,459 (13.94%)</td><td align="left" colspan="1" rowspan="1">1143 (13.76%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" colspan="1" rowspan="1">83,500 (18.90%)</td><td align="left" colspan="1" rowspan="1">81,663 (18.83%)</td><td align="left" colspan="1" rowspan="1">1837 (22.11%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Unprocessed meat intake</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;&#8201;1 times per week</td><td align="left" colspan="1" rowspan="1">83,808 (18.97%)</td><td align="left" colspan="1" rowspan="1">81,941 (18.90%)</td><td align="left" colspan="1" rowspan="1">1867 (22.47%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;1&#8211;2 times per week</td><td align="left" colspan="1" rowspan="1">218,197 (49.38%)</td><td align="left" colspan="1" rowspan="1">214,602 (49.49%)</td><td align="left" colspan="1" rowspan="1">3595 (43.27%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&gt;&#8201;2 times per week</td><td align="left" colspan="1" rowspan="1">139,172 (31.49%)</td><td align="left" colspan="1" rowspan="1">136,374 (31.45%)</td><td align="left" colspan="1" rowspan="1">2798 (33.68%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" colspan="1" rowspan="1">716 (0.16%)</td><td align="left" colspan="1" rowspan="1">668 (0.15%)</td><td align="left" colspan="1" rowspan="1">48 (0.58%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Processed meat intake</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Never</td><td align="left" colspan="1" rowspan="1">41,698 (9.44%)</td><td align="left" colspan="1" rowspan="1">40,850 (9.42%)</td><td align="left" colspan="1" rowspan="1">848 (10.21%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;&#8201;1 times per week</td><td align="left" colspan="1" rowspan="1">134,743 (30.49%)</td><td align="left" colspan="1" rowspan="1">132,646 (30.59%)</td><td align="left" colspan="1" rowspan="1">2097 (25.24%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;1 times per week</td><td align="left" colspan="1" rowspan="1">128,210 (29.01%)</td><td align="left" colspan="1" rowspan="1">126,125 (29.09%)</td><td align="left" colspan="1" rowspan="1">2085 (25.10%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;&#8201;2 times per week</td><td align="left" colspan="1" rowspan="1">136,231 (30.83%)</td><td align="left" colspan="1" rowspan="1">133,016 (30.68%)</td><td align="left" colspan="1" rowspan="1">3215 (38.70%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" colspan="1" rowspan="1">1011 (0.23%)</td><td align="left" colspan="1" rowspan="1">948 (0.22%)</td><td align="left" colspan="1" rowspan="1">63 (0.76%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Vegetable intake</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;&#8201;2 servings per day</td><td align="left" colspan="1" rowspan="1">301,254 (68.17%)</td><td align="left" colspan="1" rowspan="1">295,467 (68.15%)</td><td align="left" colspan="1" rowspan="1">5787 (69.66%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;2&#8211;3 servings per day</td><td align="left" colspan="1" rowspan="1">99,096 (22.43%)</td><td align="left" colspan="1" rowspan="1">97,479 (22.48%)</td><td align="left" colspan="1" rowspan="1">1617 (19.46%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;3&#8211;4 servings per day</td><td align="left" colspan="1" rowspan="1">24,408 (5.52%)</td><td align="left" colspan="1" rowspan="1">23,954 (5.52%)</td><td align="left" colspan="1" rowspan="1">454 (5.46%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;&#8201;4 servings per day</td><td align="left" colspan="1" rowspan="1">14,142 (3.20%)</td><td align="left" colspan="1" rowspan="1">13,823 (3.19%)</td><td align="left" colspan="1" rowspan="1">319 (3.84%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" colspan="1" rowspan="1">2993 (0.68%)</td><td align="left" colspan="1" rowspan="1">2862 (0.66%)</td><td align="left" colspan="1" rowspan="1">131 (1.58%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Tea intake</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Nondrinker</td><td align="left" colspan="1" rowspan="1">65,004 (14.71%)</td><td align="left" colspan="1" rowspan="1">63,474 (14.64%)</td><td align="left" colspan="1" rowspan="1">1530 (18.42%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;&#8201;2 cup per day</td><td align="left" colspan="1" rowspan="1">51,191 (11.58%)</td><td align="left" colspan="1" rowspan="1">50,286 (11.60%)</td><td align="left" colspan="1" rowspan="1">905 (10.89%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;2&#8211;3 cups per day</td><td align="left" colspan="1" rowspan="1">63,682 (14.41%)</td><td align="left" colspan="1" rowspan="1">62,700 (14.46%)</td><td align="left" colspan="1" rowspan="1">982 (11.82%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&gt;&#8201;3 cups per day</td><td align="left" colspan="1" rowspan="1">261,030 (59.07%)</td><td align="left" colspan="1" rowspan="1">256,216 (59.09%)</td><td align="left" colspan="1" rowspan="1">4814 (57.94%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" colspan="1" rowspan="1">986 (0.22%)</td><td align="left" colspan="1" rowspan="1">909 (0.21%)</td><td align="left" colspan="1" rowspan="1">77 (0.93%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>CKD cases</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">424,606 (96.09%)</td><td align="left" colspan="1" rowspan="1">416,936 (96.16%)</td><td align="left" colspan="1" rowspan="1">7670 (92.32%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">17,287 (3.91%)</td><td align="left" colspan="1" rowspan="1">16,649 (3.84%)</td><td align="left" colspan="1" rowspan="1">638 (7.68%)</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>Continuous variables were shown as median with interquartile range (IQR), while categorical variables were displayed as count with percentage (%). Continuous variables were compared using t test, and categorical variables using chi-squared test. <italic toggle="yes">CKD</italic> Chronic kidney disease</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec14"><title>The association between psychiatric disorders and CKD</title><p id="Par23">The proportional hazard (PH) assumption was firstly tested, as shown in Additional File 1: Supplementary Table S6, <italic toggle="yes">p</italic>-value for PH test for the association between psychiatric disorder and CKD was 0.002 in fully adjusted model, indicating a violation of the PH assumption. As depicted in Additional File 1: Supplementary Fig.&#160;1A, the cumulative incidence curves for CKD crossed between the two groups of individuals with and without psychiatric disorders, further indicating a potential violation of the PH assumption. Consequently, a Cox regression model with age as the underlying time scale was employed, as shown in Additional File 1: Supplementary Fig.&#160;1B, the two curves did not cross.</p><p id="Par24">We observed that psychiatric disorders significantly associated with 52% higher risks for following CKD (95% CI: 1.40&#8211;1.65) in fully adjusted model (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). For the subtype of 5 different psychiatric disorders at baseline separately, the highest HR was observed between stress-related disorder and CKD (HR&#8201;=&#8201;1.95, 95% CI: 1.28&#8211;2.97, <italic toggle="yes">p</italic>-value&#8201;=&#8201;0.002), and all the 5 separate psychiatric disorders at baseline significantly increased the risk of subsequent CKD (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). To further illustrate the time-varying effects of psychiatric disorders on following CKD, a flexible nonparametric smoothing model was performed. We observed that the risk of developing CKD gradually increased after the diagnosis of psychiatric disorders (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Associations between psychiatric disorders and CKD using Cox regression model with age as underlying time scale. Model 1 is not adjusted for any covariates. Model 2 is adjusted for sex. Model 3 is additionally adjusted for sociodemographic factors (ethnicity [in the primary analysis cohort only], Townsend deprivation index [in quantile], education level [college or university degree, A levels/ AS levels/ O levels/ GCSEs/ CSEs or equivalent, other degree, or unknown], annual household income [ultralow, low, medium, high, ultrahigh or unknown]), lifestyle (physical activity [low, moderate, high or unknown], vegetable intake [&lt;&#8201;2, 2&#8211;3, 3&#8211;4,&#8201;&#8805;&#8201;4 servings per day or unknown], unprocessed meat intake [&lt;&#8201;1, 1&#8211;2,&#8201;&gt;&#8201;2 times per week or unknown], processed meat intake [never,&#8201;&lt;&#8201;1, 1,&#8201;&#8805;&#8201;2 times per week or unknown] and tea intake [nondrinker,&#8201;&lt;&#8201;2, 2&#8211;3, or&#8201;&gt;&#8201;3 cups per day or unknown]), BMI (normal:&#8201;&lt;&#8201;25&#160;kg/m<sup>2</sup>, overweight: 25&#8211;30&#160;kg/m<sup>2</sup>, or obese:&#8201;&#8805;&#8201;30&#160;kg/m<sup>2</sup>), hypertension and diabetes (yes or no), Charlson comorbidity index (0, 1&#8211;2, 3&#8211;4,&#8201;&#8805;&#8201;5). CI: Confidence interval; CKD: Chronic kidney disease</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12888_2024_6461_Fig2_HTML.jpg"/></fig><fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>Time-varying hazard ratio for incident CKD among patients with psychiatric disorders by time since baseline. Time-varying hazard ratios and 95% confidence intervals were derived from flexible nonparametric smoothing models. <bold>A</bold>&#8201;&#8804;&#8201;10&#160;years after baseline. <bold>B</bold>&#8201;&gt;&#8201;10&#160;years after baseline. All models were adjusted for sex, ethnicity [in the primary analysis cohort only], Townsend deprivation index [in quantile], education level [college or university degree, A levels/ AS levels/ O levels/ GCSEs/ CSEs or equivalent, other degree, or unknown], annual household income [ultralow, low, medium, high, ultrahigh or unknown]), lifestyle (physical activity [low, moderate, high or unknown], vegetable intake [&lt;&#8201;2, 2&#8211;3, 3&#8211;4,&#8201;&#8805;&#8201;4 servings per day or unknown], unprocessed meat intake [&lt;&#8201;1, 1&#8211;2,&#8201;&gt;&#8201;2 times per week or unknown], processed meat intake [never,&#8201;&lt;&#8201;1, 1,&#8201;&#8805;&#8201;2 times per week or unknown] and tea intake [nondrinker,&#8201;&lt;&#8201;2, 2&#8211;3, or&#8201;&gt;&#8201;3 cups per day or unknown]), BMI (normal:&#8201;&lt;&#8201;25&#160;kg/m<sup>2</sup>, overweight: 25&#8211;30&#160;kg/m<sup>2</sup>, or obese:&#8201;&#8805;&#8201;30&#160;kg/m.<sup>2</sup>), hypertension and diabetes (yes or no), Charlson comorbidity index (0, 1&#8211;2, 3&#8211;4,&#8201;&#8805;&#8201;5)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="12888_2024_6461_Fig3_HTML.jpg"/></fig></p><p id="Par25">Subsequently, 297,787 participants were included in the genetic cohort. As shown in Additional File 1: Supplementary Table S7, 5,473 patients with psychiatric disorders were identified. Similarly, 1,861 (34.00%) of the psychiatric patients were under 53, while the number of individuals without psychiatric disorders was 90,307 (30.89%) in the genetic cohort. As shown in Additional File 1: Supplementary Table S8, in the genetic cohort, we identified 2,619 individuals with depression, 995 individuals with anxiety, 217 patients with stress-related disorder, 2,173 patients with substance misuse and 334 individuals with psychotic disorder. When taking genetic susceptibility to CKD into consideration, psychiatric disorders increased risks for following CKD with HR at 1.49 (95% CI: 1.35&#8211;1.65, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001) (Additional File 1: Supplementary Table S9).The HR for the association between stress-related disorders and CKD became 1.86 (95%CI: 1.14&#8211;3.04, <italic toggle="yes">p</italic>-value&#8201;=&#8201;0.013), and for psychotic disorders and CKD, it was 1.66 (95%CI: 1.06&#8211;2.60, <italic toggle="yes">p</italic>-value&#8201;=&#8201;0.028). Although these associations were nominally significant, they did not reach statistical significance after applying the Bonferroni correction for multiple comparisons (threshold at 0.05/5&#8201;=&#8201;0.01). The lack of significance may be due to the small sample sizes. Specifically, only 217 patients were identified with stress-related disorders and 334 with psychotic disorders at baseline. Among these, a mere 16 patients with stress-related disorders and 19 with psychotic disorders developed CKD during the follow up.</p></sec><sec id="Sec15"><title>Subgroup analyses</title><p id="Par26">In subgroup analyses, we observed significant differential effects of follow-up time, age at entry or exit the cohort, and the number of psychiatric disorders at baseline on the association between psychiatric disorders and CKD (<italic toggle="yes">P</italic> for interaction&#8201;&lt;&#8201;0.05, Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). The correlations between psychiatric disorders and CKD were significant in both females and males, but no interaction was observed (female: HR&#8201;=&#8201;1.51, 95% CI: 1.35&#8211;1.68,<italic toggle="yes"> p</italic>-value&#8201;&lt;&#8201;0.001; male: HR&#8201;=&#8201;1.54, 95% CI: 1.36&#8211;1.74,<italic toggle="yes"> p</italic>-value&#8201;&lt;&#8201;0.001; <italic toggle="yes">P</italic> for interaction&#8201;=&#8201;0.205). When stratified by genetic susceptibility to CKD, psychiatric disorders increased subsequent risk of CKD in all subgroups with no interaction effects. Iindividuals with medium or high genetic susceptibility had higher HRs (medium genetic risk: HR&#8201;=&#8201;1.61, 95% CI:1.35&#8211;1.90, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001; high genetic risk: HR&#8201;=&#8201;1.53, 95% CI: 1.30&#8211;1.80, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001; <italic toggle="yes">P</italic> for interaction&#8201;=&#8201;0.830).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>The hazard ratios of psychiatric disorders on CKD in subgroup analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Total (Cases)<sup>a</sup></th><th align="left" colspan="1" rowspan="1">HR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic>-value</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for interaction</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><bold>Sex</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.205</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Female</td><td align="left" colspan="1" rowspan="1">201,020(8646)</td><td align="left" colspan="1" rowspan="1">1.51 (1.35&#8211;1.68)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Male</td><td align="left" colspan="1" rowspan="1">240,873(8641)</td><td align="left" colspan="1" rowspan="1">1.54 (1.36&#8211;1.74)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Follow up time</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;&#8201;5&#160;years</td><td align="left" colspan="1" rowspan="1">9040(2966)</td><td align="left" colspan="1" rowspan="1">0.86 (0.73&#8211;1.03)</td><td align="left" colspan="1" rowspan="1">0.094</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;&#8201;5 and&#8201;&lt;&#8201;10 years</td><td align="left" colspan="1" rowspan="1">17,202(6290)</td><td align="left" colspan="1" rowspan="1">1.03 (0.91&#8211;1.18)</td><td align="left" colspan="1" rowspan="1">0.630</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;&#8201;10 and&#8201;&lt;&#8201;12 years</td><td align="left" colspan="1" rowspan="1">121,552(3931)</td><td align="left" colspan="1" rowspan="1">1.60 (1.34&#8211;1.91)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;&#8201;12 and&#8201;&lt;&#8201;13 years</td><td align="left" colspan="1" rowspan="1">149,168(2157)</td><td align="left" colspan="1" rowspan="1">1.66 (1.29&#8211;2.13)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;&#8201;13&#160;years</td><td align="left" colspan="1" rowspan="1">144,931(1943)</td><td align="left" colspan="1" rowspan="1">1.52 (1.13&#8211;2.04)</td><td align="left" colspan="1" rowspan="1">0.005</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Age entry into the cohort</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;age&#8201;&lt;&#8201;50</td><td align="left" colspan="1" rowspan="1">147,299(1804)</td><td align="left" colspan="1" rowspan="1">1.46 (1.20&#8211;1.79)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;50&#8201;&#8804;&#8201;age&#8201;&lt;&#8201;60</td><td align="left" colspan="1" rowspan="1">147,353(4939)</td><td align="left" colspan="1" rowspan="1">1.49 (1.30&#8211;1.70)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;age&#8201;&#8805;&#8201;60</td><td align="left" colspan="1" rowspan="1">147,241(10,544)</td><td align="left" colspan="1" rowspan="1">1.34 (1.19&#8211;1.51)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Age exist from the cohort</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.038</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;age&#8201;&#8804;&#8201;70</td><td align="left" colspan="1" rowspan="1">220,628(6519)</td><td align="left" colspan="1" rowspan="1">1.22 (1.10&#8211;1.37)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;age&#8201;&gt;&#8201;70</td><td align="left" colspan="1" rowspan="1">221,265(10,768)</td><td align="left" colspan="1" rowspan="1">1.32 (1.17&#8211;1.49)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Number of psychiatric disorders at baseline </bold><sup><bold>b</bold></sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;1</td><td align="left" colspan="1" rowspan="1">7163(543)</td><td align="left" colspan="1" rowspan="1">1.46 (1.34&#8211;1.60)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;2</td><td align="left" colspan="1" rowspan="1">980(79)</td><td align="left" colspan="1" rowspan="1">1.82 (1.46&#8211;2.28)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;&#8201;3</td><td align="left" colspan="1" rowspan="1">165(16)</td><td align="left" colspan="1" rowspan="1">2.96 (1.81&#8211;4.83)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Genetic risk for CKD</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.830</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Low</td><td align="left" colspan="1" rowspan="1">99,263(4651)</td><td align="left" colspan="1" rowspan="1">1.39 (1.51&#8211;1.68)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Medium</td><td align="left" colspan="1" rowspan="1">99,262(3910)</td><td align="left" colspan="1" rowspan="1">1.61 (1.35&#8211;1.90)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;High</td><td align="left" colspan="1" rowspan="1">99,262(3088)</td><td align="left" colspan="1" rowspan="1">1.53 (1.30&#8211;1.80)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>Adjusted for sex, ethnicity [in the primary analysis cohort only], Townsend deprivation index [in quantile], education level [college or university degree, A levels/ AS levels/ O levels/ GCSEs/ CSEs or equivalent, other degree, or unknown], annual household income [ultralow, low, medium, high, ultrahigh or unknown]), lifestyle (physical activity [low, moderate, high or unknown], vegetable intake [&lt;&#8201;2, 2&#8211;3, 3&#8211;4,&#8201;&#8805;&#8201;4 servings per day or unknown], unprocessed meat intake [&lt;&#8201;1, 1&#8211;2,&#8201;&gt;&#8201;2 times per week or unknown], processed meat intake [never,&#8201;&lt;&#8201;1, 1,&#8201;&#8805;&#8201;2 times per week or unknown] and tea intake [nondrinker,&#8201;&lt;&#8201;2, 2&#8211;3, or&#8201;&gt;&#8201;3 cups per day or unknown]), BMI (normal:&#8201;&lt;&#8201;25&#160;kg/m<sup>2</sup>, overweight: 25&#8211;30&#160;kg/m<sup>2</sup>, or obese:&#8201;&#8805;&#8201;30&#160;kg/m<sup>2</sup>), hypertension and diabetes (yes or no), Charlson comorbidity index (0, 1&#8211;2, 3&#8211;4,&#8201;&#8805;&#8201;5). HR, hazard ratio</p><p><sup>a</sup> Total number of individuals in each subgroup with the number of CKD cases in each subgroup</p><p><sup>b</sup> For each subgroup, 433,585 individuals without psychiatric disorders (with 16,649 developed CKD) were included as control</p></table-wrap-foot></table-wrap></p><p id="Par27">Interestingly, the increased risk for subsequent CKD was only observed in individuals followed up for more than 10&#160;years (10&#8211;12&#160;years: HR&#8201;=&#8201;1.60, 95% CI: 1.34&#8211;1.91, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001; 12&#8211;13&#160;years: HR&#8201;=&#8201;1.66, 95% CI: 1.29&#8211;2.13, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001;&#8201;&#8805;&#8201;13&#160;years: HR&#8201;=&#8201;1.52, 95% CI: 1.13&#8211;2.04, <italic toggle="yes">p</italic>-value&#8201;=&#8201;0.005; <italic toggle="yes">P</italic> for interaction&#8201;&lt;&#8201;0.001). Individuals with more than 3 subtypes of psychiatric disorders at baseline had a higher risk of CKD (number&#8201;=&#8201;1: HR&#8201;=&#8201;1.46, 95% CI: 1.34&#8211;1.60, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001; number&#8201;=&#8201;2: HR&#8201;=&#8201;1.82, 95% CI: 1.46&#8211;2.28, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001; number&#8201;&#8805;&#8201;3: HR&#8201;=&#8201;2.96, 95% CI: 1.81&#8211;4.83,<italic toggle="yes"> p</italic>-value&#8201;&lt;&#8201;0.001; <italic toggle="yes">P</italic> for interaction&#8201;&lt;&#8201;0.001). In addition, the association was much higher among individuals with older age exit from the cohort (age&#8201;&#8804;&#8201;70: HR&#8201;=&#8201;1.22, 95% CI: 1.10&#8211;1.37, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001; age&#8201;&gt;&#8201;70: HR&#8201;=&#8201;1.32, 95% CI: 1.17&#8211;1.49, <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.001; <italic toggle="yes">P</italic> for interaction&#8201;=&#8201;0.038) (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).</p><p id="Par28">In sensitivity analyses, results were unchanged after excluding participants diagnosed with CKD within 1, 2, and 5&#160;years (Additional File 1: Supplementary Figure S2, S3 and S4). When further excluding individuals with BMI&#8201;&lt;&#8201;16.5 kg/m<sup>2</sup> or&#8201;&gt;&#8201;40 kg/m<sup>2</sup>, the results were not significantly changed (Additional File 1: Supplementary Figure S5). As shown in Additional File 1: Supplementary Table S10, when all-cause and CKD death were considered as a competing risk, psychiatric disorders still significantly increased the risk of CKD.</p></sec><sec id="Sec16"><title>Mediation analyses</title><p id="Par29">Mediation analyses showed that BMI and hypertension mediated some proportion of the association between psychiatry disorders and CKD (Supplementary Table S11 and Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>). Hypertension turned out to be the most prominent mediator, which mediated 49.13% (95% CI: 37.60% to 67.08%) of the total effect. We also observed significant mediating effects for BMI and diabetes, which mediated 12.11% (95% CI: 8.49% to 17.24%) and 3.78% (95% CI: 1.58%&#8722;6.52%) of the total effects.<fig id="Fig4" position="float" orientation="portrait"><label>Fig.&#160;4</label><caption><p>Path diagram of the significant mediators of BMI and hypertension on the association between psychiatric disorders and CKD. <bold>A</bold> Mediating role of BMI. <bold>B</bold> Mediating role of hypertension</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="12888_2024_6461_Fig4_HTML.jpg"/></fig></p></sec></sec><sec id="Sec17"><title>Discussion</title><p id="Par30">By using a large-scale community-based cohort in the UK with more than 500,000 participants, we observed that psychiatric disorders increased the risk of subsequent CKD. Specifically, patients who are under the age of 60, have multiple psychiatric morbidities, or have been diagnosed with psychiatric disorders for over 10 years are at higher risk of developing CKD. BMI and hypertension might be the mediators involved in the positive association between psychiatric disorders and CKD. Our findings add evidence of the relationship between psychiatric disorders and subsequent CKD.</p><p id="Par31">The major strength in our study is the identification of delayed onset of increased risk for CKD in patients with psychiatric disorders. Only patients who had been diagnosed with psychiatric disorders for over 10 years exhibited an elevated risk of developing CKD. By employing a flexible nonparametric smoothing model, we observed a tendency for the hazard ratio to increase among patients with psychiatric disorders, and became significant after about 3000&#160;days (10 years) follow-ups. In subgroup analysis, we observed a higher risk for CKD among psychiatric patients who entered the cohort at an age of less than 60 and exited the cohort at an age greater than 70, which also suggests that the effects of psychiatric disorders on the risk of CKD may persist over a prolonged period. Young people are more susceptible to both mental illnesses [<xref ref-type="bibr" rid="CR47">47</xref>] and CKD [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>], which could potentially explain the higher incidence of psychiatric disorders and higher risk for developing CKD among psychiatric patients who aged under 60 at baseline. For patients exit the cohort aged greater than 70, the higher risk for CKD might result from the age-related structure and function changes of kidney as well as decline in renal function [<xref ref-type="bibr" rid="CR50">50</xref>]. The possible reasons accounted for the delayed onset of increased risk for CKD included cumulative physiological stress, or chronic inflammatory response. Specifically, cumulative exposure to psychiatric disorder will lead to dysregulation of physiological stress system (e.g., the hypothalamic&#8211;pituitary&#8211;adrenal axis) [<xref ref-type="bibr" rid="CR51">51</xref>], further resulting in cellular aging and chronic inflammatory response [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. The chronic inflammatory response will accumulate neutrophils and macrophages, resulting in inflammatory injury and kidney fibrosis, followed by CKD progression [<xref ref-type="bibr" rid="CR54">54</xref>]. Our recent study has provided evidence that inflammatory response (like interleukin 1 receptor and cytokine receptor activities) were important factors mediating the association between the patterns of exposure to adverse life events and the risk of subsequent CKD [<xref ref-type="bibr" rid="CR33">33</xref>]. In addition, the low awareness of early CKD and delayed detection of the disease [<xref ref-type="bibr" rid="CR55">55</xref>] may also partly explain the delayed onset of increased risk for CKD in patients with psychiatric disorders.</p><p id="Par32">We observed that hypertension, BMI and diabetes, common risk factors for CKD, are significant mediators in the relationship between psychiatric disorders and CKD. Among these, hypertension turned out to be the most prominent mediator mediating 49.13% of the total effect. The mediating roles of hypertension observed in our study are consistent with many previous studies reporting the increased risk for subsequent adverse cardiovascular events in patients with various psychiatric disorders [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Stress-related disorders associated with early onset of cardiovascular disease, exhibiting higher hazard ratio within the first year after diagnosis [<xref ref-type="bibr" rid="CR14">14</xref>]. The mediating role of hypertension is quite complex, as it is not only a strong determinant of worse kidney and cardiovascular outcomes but also a consequence of decreased kidney function where renal function decline aggravates hypertension [<xref ref-type="bibr" rid="CR56">56</xref>]. Diabetes, another key mediator, has also been widely reported to be associated with psychiatric disorder [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Diabetes is a common risk factor for CKD, has been reported to be associated with glomerular hyperfiltration and total GFR increase [<xref ref-type="bibr" rid="CR6">6</xref>]. Obesity is known to induce a chronic low-grade inflammatory state and release adipokines that can directly impair kidney function [<xref ref-type="bibr" rid="CR59">59</xref>]. Depression and anxiety have been reported to be associated with obesity [<xref ref-type="bibr" rid="CR60">60</xref>], with secretion of adipokines, including glomerular hyperfiltration [<xref ref-type="bibr" rid="CR61">61</xref>]. However, obesity, hypertension and diabetes themselves may interact with each other [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>], making the mediating roles more complicated. For example, obesity and hypertension are important drivers of microvascular dysfunction in type 2 diabetes, which are associated with several brain diseases and depression [<xref ref-type="bibr" rid="CR64">64</xref>]. Therefore, the intricate relationships among obesity, hypertension, and diabetes that influence the association between psychiatric disorders and chronic kidney disease (CKD) necessitate further exploration, and the underlying molecular mechanisms involved are eagerly awaited to be unraveled. Furthermore, it has been reported that the progression of CKD might worsen psychiatric symptoms [<xref ref-type="bibr" rid="CR65">65</xref>], potentially creating a bidirectional relationship between psychiatric disorders and CKD that still requires deeper investigation in the future.</p><p id="Par33">Our findings in line with previous studies reported the significant positive association between psychiatric disorders, including depression [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>], anxiety [<xref ref-type="bibr" rid="CR68">68</xref>], substance misuse [<xref ref-type="bibr" rid="CR69">69</xref>], psychotic disorder [<xref ref-type="bibr" rid="CR70">70</xref>] or stress-related disorders [<xref ref-type="bibr" rid="CR14">14</xref>] and a rapid decline in kidney function or risk for developing CKD. However, few studies focused on the time-varying effects of psychiatric disorders on the subsequent risk of CKD. In our study, the strongest association was observed between stress-related disorders and chronic kidney disease (CKD). However, after further adjusting genetic risk for CKD and applying the Bonferroni correction for multiple comparisons, this association did not reach statistical significance which may be attributed to the limited sample size. Similarly, the association between psychotic disorders and CKD did not pass Bonferroni correction either, after further considering genetic susceptibility to CKD. As more data become available, it will be important to further explore the relationship between psychiatric disorders and CKD considering genetic susceptibility.</p><p id="Par34">The findings revealed by subgroup analyses can facilitate more effective screening and preventive strategies in specific populations with higher risks, such as psychiatric patients under the age of 60, individuals with multiple psychiatric morbidities, or those who have been diagnosed with psychiatric disorders for over 10 years. Our research also provided evidence that lifestyle interventions (for example losing weight, healthy diet or physical exercise) targeting mediators of BMI, hypertension, and diabetes, together with routine monitoring of kidney function as well as early screening and diagnosis of CKD, may be potential strategies for preventing the progression to CKD in patients with psychiatric disorders, especially the psychiatric populations with higher risks. Furthermore, the tailored management of hypertension, diabetes and obesity, as well as the implementation of integrated psychiatric and renal care models, are also possible strategies to prevent CKD progression in these populations.</p><p id="Par35">There are also some limitations to be pointed out. Firstly, this study is mainly composed of individuals with a median age of 57.97&#160;years, making it difficult to extrapolate our results to, for example, younger patients aged 20&#8211;40&#160;years. Secondly, the exclusion of non-Caucasian participants in the genetic cohort may limit the generalizability of our findings to other populations. Also, a &#8220;healthy volunteer&#8221; selection bias regarding UK Biobank has been identified. Thirdly, some potential residual confounders that are difficult to detect were not included in our study. In addition, some confounders such as BMI, diet, education and income levels used in our study were based on the measured at the baseline survey, the potential measurement error might exist, this may lead to bias in the analysis. Fifthly, because this study mainly focused on patients who received a clinical diagnosis of psychiatric disorders through hospitalization with reliance on inpatient records, participants with mild or subclinical psychiatric symptoms that were managed in primary care or remained undiagnosed were not included in our study. This exclusion may have led to an underestimation of the number of psychiatric disorder cases and limited the generalizability of the study to individuals with milder psychiatric symptoms. Further research focusing on the association between milder psychiatric disorders and the risk of subsequent CKD will be a promising direction in the future. In addition, due to the low awareness of early CKD and the influence of healthcare-seeking behavior, newly developed cases of incident CKD may also be underdiagnosed. Finally, the delayed onset of increased risk for CKD was observed after 10 years of follow-up might partly result from the delayed detection of CKD, which may bias the observation.</p><p id="Par36">In conclusion, psychiatric disorders were found to be associated with a delayed onset of enhanced risk for subsequent CKD. Patients with psychiatric conditions who are under the age of 60, with multiple psychiatric morbidities or having been diagnosed with psychiatric disorders for over 10 years may be high-risk populations. Additionally, BMI, hypertension, and diabetes emerged as potential mediators involved in the relationship between psychiatric disorders and CKD. Our study highlights the significance of lifestyle interventions, routine monitoring of kidney function, early screening for CKD, and personalized management strategies for psychiatric patients as potential approaches to the precise prevention of CKD.</p></sec><sec id="Sec18" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12888_2024_6461_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Additional file 1.</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Hanfei Li and Chunyang Li contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This research was conducted using the UK Biobank Resource under Application 54803. This work uses data provided by patients and collected by the National Health Service as part of their care and support. This research used data assets made available by National Safe Haven as part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref: MC_PC_20029 and MC_PC_20058).</p><sec id="FPar1"><title>Clinical trial number</title><p id="Par37">Not applicable.</p></sec></ack><notes notes-type="author-contribution"><title>Authors' contributions</title><p>Hanfei Li: Validation, Formal analysis, Investigation, Writing-Original Draft, Visualization. Chunyang Li: Conceptualization, Resources, Writing-Review &amp; Editing. Chao Zhang: Validation. Zhiye Ying: Formal analysis. Chuanfang Wu: Validation. Xiaoxi Zeng: Supervision, Project administration, Resources, Data Curation. Jinku Bao: Supervision.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by Key Research and Development Program of Chengdu [2021-YF08-00167-GX], the 1&#8226;3&#8226;5 project for disciplines of excellence, West China Hospital, Sichuan University [ZYJC18010], and Digital Economy Pilot Project for Application of Healthcare Big Data from National Development and Reform Commission of China [2018gfgw001].</p></notes><notes notes-type="data-availability"><title>Data availability
</title><p>The datasets supporting the conclusions of this article are available in the website of the UK Biobank (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://biobank.ndph.ox.ac.uk/ukb/exinfo.cgi?src=Data_providers_and_dates">https://biobank.ndph.ox.ac.uk/ukb/exinfo.cgi?src=Data_providers_and_dates</ext-link>).</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par38">All the UK Biobank participants gave written informed consent before data collection. The UK Biobank has full ethical approval from the NHS National Research Ethics Service (16/NW/0274), and this study was approved by the biomedical research ethics committee of West China Hospital (2019&#8211;1171).</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par39">No identifiable images were used in this manuscript, so consent to publish was not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests
</title><p id="Par40">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><collab>GBD Chronic Kidney Disease Collaboration</collab></person-group><article-title>Global, regional, and national burden of chronic kidney disease, 1990&#8211;2017: a systematic analysis for the Global Burden of Disease Study 2017</article-title><source>Lancet</source><year>2020</year><volume>395</volume><issue>10225</issue><fpage>709</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30045-3</pub-id><pub-id pub-id-type="pmid">32061315</pub-id><pub-id pub-id-type="pmcid">PMC7049905</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990&#8211;2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709&#8211;33. 10.1016/S0140-6736(20)30045-3.<pub-id pub-id-type="pmid">32061315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30045-3</pub-id><pub-id pub-id-type="pmcid">PMC7049905</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">The Global Burden of Disease tools. The mortality of CKD. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://vizhub.healthdata.org/gbd-results">https://vizhub.healthdata.org/gbd-results</ext-link>.</mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carswell</surname><given-names>C</given-names></name><name name-style="western"><surname>Cogley</surname><given-names>C</given-names></name><name name-style="western"><surname>Bramham</surname><given-names>K</given-names></name><name name-style="western"><surname>Chilcot</surname><given-names>J</given-names></name><name name-style="western"><surname>Noble</surname><given-names>H</given-names></name><name name-style="western"><surname>Siddiqi</surname><given-names>N</given-names></name></person-group><article-title>Chronic kidney disease and severe mental illness: a scoping review</article-title><source>J Nephrol</source><year>2023</year><volume>36</volume><issue>6</issue><fpage>1519</fpage><lpage>1547</lpage><pub-id pub-id-type="doi">10.1007/s40620-023-01599-8</pub-id><pub-id pub-id-type="pmid">37029882</pub-id><pub-id pub-id-type="pmcid">PMC10393892</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Carswell C, Cogley C, Bramham K, Chilcot J, Noble H, Siddiqi N. Chronic kidney disease and severe mental illness: a scoping review. J Nephrol. 2023;36(6):1519&#8211;47. 10.1007/s40620-023-01599-8.<pub-id pub-id-type="pmid">37029882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40620-023-01599-8</pub-id><pub-id pub-id-type="pmcid">PMC10393892</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">USRDS. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://usrds-adr.niddk.nih.gov/2023/end-stage-renal-disease/1-incidence-prevalence-patient-characteristics-and-treatment-modalities">https://usrds-adr.niddk.nih.gov/2023/end-stage-renal-disease/1-incidence-prevalence-patient-characteristics-and-treatment-modalities</ext-link>.</mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>V</given-names></name><name name-style="western"><surname>Vilme</surname><given-names>H</given-names></name><name name-style="western"><surname>Maciejewski</surname><given-names>ML</given-names></name><name name-style="western"><surname>Boulware</surname><given-names>LE</given-names></name></person-group><article-title>The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease</article-title><source>Semin Nephrol</source><year>2016</year><volume>36</volume><issue>4</issue><fpage>319</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.semnephrol.2016.05.008</pub-id><pub-id pub-id-type="pmid">27475662</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Wang V, Vilme H, Maciejewski ML, Boulware LE. The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease. Semin Nephrol. 2016;36(4):319&#8211;30. 10.1016/j.semnephrol.2016.05.008.<pub-id pub-id-type="pmid">27475662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semnephrol.2016.05.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Webster</surname><given-names>AC</given-names></name><name name-style="western"><surname>Nagler</surname><given-names>EV</given-names></name><name name-style="western"><surname>Morton</surname><given-names>RL</given-names></name><name name-style="western"><surname>Masson</surname><given-names>P</given-names></name></person-group><article-title>Chronic Kidney Disease</article-title><source>Lancet</source><year>2017</year><volume>389</volume><issue>10075</issue><fpage>1238</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)32064-5</pub-id><pub-id pub-id-type="pmid">27887750</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238&#8211;52. 10.1016/S0140-6736(16)32064-5.<pub-id pub-id-type="pmid">27887750</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(16)32064-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Bu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qi</surname><given-names>M</given-names></name><name name-style="western"><surname>Fu</surname><given-names>P</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name></person-group><article-title>Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040</article-title><source>Chin Med J (Engl)</source><year>2024</year><pub-id pub-id-type="doi">10.1097/CM9.0000000000003143</pub-id><pub-id pub-id-type="pmid">38809055</pub-id><pub-id pub-id-type="pmcid">PMC12150917</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Chen J, Li C, Bu C, Wang Y, Qi M, Fu P, Zeng X. Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040. Chin Med J (Engl). 2024. 10.1097/CM9.0000000000003143.<pub-id pub-id-type="pmid">38809055</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CM9.0000000000003143</pub-id><pub-id pub-id-type="pmcid">PMC12150917</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elser</surname><given-names>H</given-names></name><name name-style="western"><surname>Horv&#225;th-Puh&#243;</surname><given-names>E</given-names></name><name name-style="western"><surname>Gradus</surname><given-names>JL</given-names></name><name name-style="western"><surname>Smith</surname><given-names>ML</given-names></name><name name-style="western"><surname>Lash</surname><given-names>TL</given-names></name><name name-style="western"><surname>Glymour</surname><given-names>MM</given-names></name><name name-style="western"><surname>S&#248;rensen</surname><given-names>HT</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>VW</given-names></name></person-group><article-title>Association of Early-, Middle-, and Late-Life Depression With Incident Dementia in a Danish Cohort</article-title><source>JAMA Neurol</source><year>2023</year><volume>80</volume><issue>9</issue><fpage>949</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2023.2309</pub-id><pub-id pub-id-type="pmid">37486689</pub-id><pub-id pub-id-type="pmcid">PMC10366950</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Elser H, Horv&#225;th-Puh&#243; E, Gradus JL, Smith ML, Lash TL, Glymour MM, S&#248;rensen HT, Henderson VW. Association of Early-, Middle-, and Late-Life Depression With Incident Dementia in a Danish Cohort. JAMA Neurol. 2023;80(9):949&#8211;58. 10.1001/jamaneurol.2023.2309.<pub-id pub-id-type="pmid">37486689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2023.2309</pub-id><pub-id pub-id-type="pmcid">PMC10366950</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>W</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Joo</surname><given-names>JH</given-names></name><name name-style="western"><surname>Jang</surname><given-names>SI</given-names></name><name name-style="western"><surname>Park</surname><given-names>EC</given-names></name></person-group><article-title>Association between depression and risk of Parkinson's disease in South Korean adults</article-title><source>J Affect Disord</source><year>2021</year><volume>292</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2021.05.038</pub-id><pub-id pub-id-type="pmid">34102551</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Jeong W, Kim H, Joo JH, Jang SI, Park EC. Association between depression and risk of Parkinson&#8217;s disease in South Korean adults. J Affect Disord. 2021;292:75&#8211;80. 10.1016/j.jad.2021.05.038.<pub-id pub-id-type="pmid">34102551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jad.2021.05.038</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leschik</surname><given-names>J</given-names></name><name name-style="western"><surname>Lutz</surname><given-names>B</given-names></name><name name-style="western"><surname>Gentile</surname><given-names>A</given-names></name></person-group><article-title>Stress-Related Dysfunction of Adult Hippocampal Neurogenesis-An Attempt for Understanding Resilience</article-title><source>Int J Mol Sci</source><year>2021</year><volume>22</volume><issue>14</issue><fpage>7339</fpage><pub-id pub-id-type="doi">10.3390/ijms22147339</pub-id><pub-id pub-id-type="pmid">34298958</pub-id><pub-id pub-id-type="pmcid">PMC8305135</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Leschik J, Lutz B, Gentile A. Stress-Related Dysfunction of Adult Hippocampal Neurogenesis-An Attempt for Understanding Resilience. Int J Mol Sci. 2021;22(14):7339. 10.3390/ijms22147339.<pub-id pub-id-type="pmid">34298958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22147339</pub-id><pub-id pub-id-type="pmcid">PMC8305135</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>LF</given-names></name><name name-style="western"><surname>Solmi</surname><given-names>M</given-names></name><name name-style="western"><surname>Cortese</surname><given-names>S</given-names></name></person-group><article-title>Association between anxiety and hypertension in adults: A systematic review and meta-analysis</article-title><source>Neurosci Biobehav Rev</source><year>2021</year><volume>131</volume><fpage>96</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2021.08.031</pub-id><pub-id pub-id-type="pmid">34481847</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Lim LF, Solmi M, Cortese S. Association between anxiety and hypertension in adults: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;131:96&#8211;119. 10.1016/j.neubiorev.2021.08.031.<pub-id pub-id-type="pmid">34481847</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neubiorev.2021.08.031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Freedland</surname><given-names>KE</given-names></name><name name-style="western"><surname>Clouse</surname><given-names>RE</given-names></name><name name-style="western"><surname>Lustman</surname><given-names>PJ</given-names></name></person-group><article-title>The prevalence of comorbid depression in adults with diabetes: a meta-analysis</article-title><source>Diabetes Care</source><year>2001</year><volume>24</volume><issue>6</issue><fpage>1069</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.2337/diacare.24.6.1069</pub-id><pub-id pub-id-type="pmid">11375373</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069&#8211;78. 10.2337/diacare.24.6.1069.<pub-id pub-id-type="pmid">11375373</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/diacare.24.6.1069</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hare</surname><given-names>DL</given-names></name><name name-style="western"><surname>Toukhsati</surname><given-names>SR</given-names></name><name name-style="western"><surname>Johansson</surname><given-names>P</given-names></name><name name-style="western"><surname>Jaarsma</surname><given-names>T</given-names></name></person-group><article-title>Depression and cardiovascular disease: a clinical review</article-title><source>Eur Heart J</source><year>2014</year><volume>35</volume><issue>21</issue><fpage>1365</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/eht462</pub-id><pub-id pub-id-type="pmid">24282187</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365&#8211;72. 10.1093/eurheartj/eht462.<pub-id pub-id-type="pmid">24282187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/eht462</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>H</given-names></name><name name-style="western"><surname>Fang</surname><given-names>F</given-names></name><name name-style="western"><surname>Arnberg</surname><given-names>FK</given-names></name><name name-style="western"><surname>Mataix-Cols</surname><given-names>D</given-names></name><name name-style="western"><surname>Fern&#225;ndez de la Cruz </surname><given-names>L</given-names></name><name name-style="western"><surname>Almqvist</surname><given-names>C</given-names></name><name name-style="western"><surname>Fall</surname><given-names>K</given-names></name><name name-style="western"><surname>Lichtenstein</surname><given-names>P</given-names></name><name name-style="western"><surname>Thorgeirsson</surname><given-names>G</given-names></name><name name-style="western"><surname>Valdimarsd&#243;ttir</surname><given-names>UA</given-names></name></person-group><article-title>Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study</article-title><source>BMJ.</source><year>2019</year><volume>365</volume><fpage>l1255</fpage><pub-id pub-id-type="doi">10.1136/bmj.l1255</pub-id><pub-id pub-id-type="pmid">30971390</pub-id><pub-id pub-id-type="pmcid">PMC6457109</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Song H, Fang F, Arnberg FK, Mataix-Cols D, Fern&#225;ndez de la Cruz L, Almqvist C, Fall K, Lichtenstein P, Thorgeirsson G, Valdimarsd&#243;ttir UA. Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study. BMJ. 2019;365:l1255. 10.1136/bmj.l1255.<pub-id pub-id-type="pmid">30971390</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.l1255</pub-id><pub-id pub-id-type="pmcid">PMC6457109</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rashid</surname><given-names>S</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>AG</given-names></name><name name-style="western"><surname>Noor</surname><given-names>TA</given-names></name><name name-style="western"><surname>Yaseen</surname><given-names>K</given-names></name><name name-style="western"><surname>Sheikh</surname><given-names>M</given-names></name><name name-style="western"><surname>Malik</surname><given-names>M</given-names></name><name name-style="western"><surname>Malik</surname><given-names>J</given-names></name></person-group><article-title>Anxiety and Depression in Heart Failure: An Updated Review</article-title><source>Curr Probl Cardiol.</source><year>2023</year><volume>48</volume><issue>11</issue><fpage>101987</fpage><pub-id pub-id-type="doi">10.1016/j.cpcardiol.2023.101987</pub-id><pub-id pub-id-type="pmid">37473952</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Rashid S, Qureshi AG, Noor TA, Yaseen K, Sheikh M, Malik M, Malik J. Anxiety and Depression in Heart Failure: An Updated Review. Curr Probl Cardiol. 2023;48(11):101987. 10.1016/j.cpcardiol.2023.101987.<pub-id pub-id-type="pmid">37473952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cpcardiol.2023.101987</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorman</surname><given-names>JM</given-names></name><name name-style="western"><surname>Sloan</surname><given-names>RP</given-names></name></person-group><article-title>Heart rate variability in depressive and anxiety disorders</article-title><source>Am Heart J</source><year>2000</year><volume>140</volume><issue>4 Suppl</issue><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1067/mhj.2000.109981</pub-id><pub-id pub-id-type="pmid">11011352</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000;140(4 Suppl):77&#8211;83. 10.1067/mhj.2000.109981.<pub-id pub-id-type="pmid">11011352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mhj.2000.109981</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Suo</surname><given-names>C</given-names></name><name name-style="western"><surname>Yao</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>D</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>H</given-names></name><name name-style="western"><surname>D'Onofrio</surname><given-names>BM</given-names></name><name name-style="western"><surname>Lichtenstein</surname><given-names>P</given-names></name><name name-style="western"><surname>Fang</surname><given-names>F</given-names></name><name name-style="western"><surname>Valdimarsd&#243;ttir</surname><given-names>UA</given-names></name><name name-style="western"><surname>Song</surname><given-names>H</given-names></name></person-group><article-title>Genetic Associations Between Stress-Related Disorders and Autoimmune Disease</article-title><source>Am J Psychiatry</source><year>2023</year><volume>180</volume><issue>4</issue><fpage>294</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.20220364</pub-id><pub-id pub-id-type="pmid">37002690</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Zeng Y, Suo C, Yao S, Lu D, Larsson H, D&#8217;Onofrio BM, Lichtenstein P, Fang F, Valdimarsd&#243;ttir UA, Song H. Genetic Associations Between Stress-Related Disorders and Autoimmune Disease. Am J Psychiatry. 2023;180(4):294&#8211;304. 10.1176/appi.ajp.20220364.<pub-id pub-id-type="pmid">37002690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ajp.20220364</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Association of pre-existing depression and anxiety with Omicron variant infection</article-title><source>Mol Psychiatry</source><year>2024</year><volume>29</volume><issue>11</issue><fpage>3422</fpage><lpage>3430</lpage><pub-id pub-id-type="doi">10.1038/s41380-024-02594-6</pub-id><pub-id pub-id-type="pmid">38755244</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Yang H, Yang L, Chen W, Zeng Y, Zhang Y, Tang Y, Zeng H, Yang D, Qu Y, Hu Y, et al. Association of pre-existing depression and anxiety with Omicron variant infection. Mol Psychiatry. 2024;29(11):3422&#8211;30. 10.1038/s41380-024-02594-6.<pub-id pub-id-type="pmid">38755244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41380-024-02594-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>F</given-names></name><name name-style="western"><surname>Fang</surname><given-names>F</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ye</surname><given-names>W</given-names></name><name name-style="western"><surname>Valdimarsd&#243;ttir</surname><given-names>UA</given-names></name><name name-style="western"><surname>Song</surname><given-names>H</given-names></name></person-group><article-title>Stress-related disorders and subsequent cancer risk and mortality: a population-based and sibling-controlled cohort study in Sweden</article-title><source>Eur J Epidemiol</source><year>2022</year><volume>37</volume><issue>9</issue><fpage>947</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1007/s10654-022-00898-x</pub-id><pub-id pub-id-type="pmid">35962878</pub-id><pub-id pub-id-type="pmcid">PMC9529708</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Tian F, Fang F, Shen Q, Ye W, Valdimarsd&#243;ttir UA, Song H. Stress-related disorders and subsequent cancer risk and mortality: a population-based and sibling-controlled cohort study in Sweden. Eur J Epidemiol. 2022;37(9):947&#8211;58. 10.1007/s10654-022-00898-x.<pub-id pub-id-type="pmid">35962878</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10654-022-00898-x</pub-id><pub-id pub-id-type="pmcid">PMC9529708</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>X</given-names></name><name name-style="western"><surname>Hou</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Ying</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Valdimarsd&#243;ttir</surname><given-names>UA</given-names></name><etal/></person-group><article-title>Disease trajectories and mortality among individuals diagnosed with depression: a community-based cohort study in UK Biobank</article-title><source>Mol Psychiatry</source><year>2021</year><volume>26</volume><issue>11</issue><fpage>6736</fpage><lpage>6746</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01170-6</pub-id><pub-id pub-id-type="pmid">34035478</pub-id><pub-id pub-id-type="pmcid">PMC8145187</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Han X, Hou C, Yang H, Chen W, Ying Z, Hu Y, Sun Y, Qu Y, Yang L, Valdimarsd&#243;ttir UA, et al. Disease trajectories and mortality among individuals diagnosed with depression: a community-based cohort study in UK Biobank. Mol Psychiatry. 2021;26(11):6736&#8211;46. 10.1038/s41380-021-01170-6.<pub-id pub-id-type="pmid">34035478</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41380-021-01170-6</pub-id><pub-id pub-id-type="pmcid">PMC8145187</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halen</surname><given-names>NV</given-names></name><name name-style="western"><surname>Cukor</surname><given-names>D</given-names></name><name name-style="western"><surname>Constantiner</surname><given-names>M</given-names></name><name name-style="western"><surname>Kimmel</surname><given-names>PL</given-names></name></person-group><article-title>Depression and mortality in end-stage renal disease</article-title><source>Curr Psychiatry Rep</source><year>2012</year><volume>14</volume><issue>1</issue><fpage>36</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/s11920-011-0248-5</pub-id><pub-id pub-id-type="pmid">22105534</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Halen NV, Cukor D, Constantiner M, Kimmel PL. Depression and mortality in end-stage renal disease. Curr Psychiatry Rep. 2012;14(1):36&#8211;44. 10.1007/s11920-011-0248-5.<pub-id pub-id-type="pmid">22105534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11920-011-0248-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudlow</surname><given-names>C</given-names></name><name name-style="western"><surname>Gallacher</surname><given-names>J</given-names></name><name name-style="western"><surname>Allen</surname><given-names>N</given-names></name><name name-style="western"><surname>Beral</surname><given-names>V</given-names></name><name name-style="western"><surname>Burton</surname><given-names>P</given-names></name><name name-style="western"><surname>Danesh</surname><given-names>J</given-names></name><name name-style="western"><surname>Downey</surname><given-names>P</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>P</given-names></name><name name-style="western"><surname>Green</surname><given-names>J</given-names></name><name name-style="western"><surname>Landray</surname><given-names>M</given-names></name><etal/></person-group><article-title>UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age</article-title><source>PLoS Med.</source><year>2015</year><volume>12</volume><issue>3</issue><fpage>e1001779</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001779</pub-id><pub-id pub-id-type="pmid">25826379</pub-id><pub-id pub-id-type="pmcid">PMC4380465</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. 10.1371/journal.pmed.1001779.<pub-id pub-id-type="pmid">25826379</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.1001779</pub-id><pub-id pub-id-type="pmcid">PMC4380465</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manichaikul</surname><given-names>A</given-names></name><name name-style="western"><surname>Mychaleckyj</surname><given-names>JC</given-names></name><name name-style="western"><surname>Rich</surname><given-names>SS</given-names></name><name name-style="western"><surname>Daly</surname><given-names>K</given-names></name><name name-style="western"><surname>Sale</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WM</given-names></name></person-group><article-title>Robust relationship inference in genome-wide association studies</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><issue>22</issue><fpage>2867</fpage><lpage>2873</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq559</pub-id><pub-id pub-id-type="pmid">20926424</pub-id><pub-id pub-id-type="pmcid">PMC3025716</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26(22):2867&#8211;73. 10.1093/bioinformatics/btq559.<pub-id pub-id-type="pmid">20926424</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btq559</pub-id><pub-id pub-id-type="pmcid">PMC3025716</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Mikkelsen</surname><given-names>DH</given-names></name><name name-style="western"><surname>Luitva</surname><given-names>LB</given-names></name><name name-style="western"><surname>Song</surname><given-names>H</given-names></name><name name-style="western"><surname>Kasela</surname><given-names>S</given-names></name><name name-style="western"><surname>Aspelund</surname><given-names>T</given-names></name><name name-style="western"><surname>Bergstedt</surname><given-names>J</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>PF</given-names></name><name name-style="western"><surname>Ye</surname><given-names>W</given-names></name><etal/></person-group><article-title>Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countries</article-title><source>EClinicalMedicine</source><year>2023</year><volume>61</volume><fpage>102063</fpage><pub-id pub-id-type="doi">10.1016/j.eclinm.2023.102063</pub-id><pub-id pub-id-type="pmid">37425374</pub-id><pub-id pub-id-type="pmcid">PMC10329128</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Shen Q, Mikkelsen DH, Luitva LB, Song H, Kasela S, Aspelund T, Bergstedt J, Lu Y, Sullivan PF, Ye W, et al. Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countries. EClinicalMedicine. 2023;61:102063. 10.1016/j.eclinm.2023.102063.<pub-id pub-id-type="pmid">37425374</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eclinm.2023.102063</pub-id><pub-id pub-id-type="pmcid">PMC10329128</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ying</surname><given-names>Z</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis</article-title><source>Lancet Healthy Longev.</source><year>2020</year><volume>1</volume><issue>2</issue><fpage>e69</fpage><lpage>69e79</lpage><pub-id pub-id-type="doi">10.1016/S2666-7568(20)30013-1</pub-id><pub-id pub-id-type="pmid">33521769</pub-id><pub-id pub-id-type="pmcid">PMC7832159</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Yang H, Chen W, Hu Y, Chen Y, Zeng Y, Sun Y, Ying Z, He J, Qu Y, Lu D, et al. Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis. Lancet Healthy Longev. 2020;1(2):e69-69e79. 10.1016/S2666-7568(20)30013-1.<pub-id pub-id-type="pmid">33521769</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2666-7568(20)30013-1</pub-id><pub-id pub-id-type="pmcid">PMC7832159</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><collab>Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group</collab></person-group><article-title>KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease</article-title><source>Kidney Int.</source><year>2024</year><volume>105</volume><issue>4S</issue><fpage>S117</fpage><lpage>117S314</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2023.10.018</pub-id><pub-id pub-id-type="pmid">38490803</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-117S314. 10.1016/j.kint.2023.10.018.<pub-id pub-id-type="pmid">38490803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.kint.2023.10.018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Song</surname><given-names>H</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Sex-specific association between coffee consumption and incident chronic kidney disease: a population-based analysis of 359,906 participants from the UK Biobank</article-title><source>Chin Med J (Engl)</source><year>2022</year><volume>135</volume><issue>12</issue><fpage>1414</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1097/CM9.0000000000002234</pub-id><pub-id pub-id-type="pmid">35940879</pub-id><pub-id pub-id-type="pmcid">PMC9481436</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Tang L, Yang L, Chen W, Li C, Zeng Y, Yang H, Hu Y, Qu Y, Song H, Zeng X, et al. Sex-specific association between coffee consumption and incident chronic kidney disease: a population-based analysis of 359,906 participants from the UK Biobank. Chin Med J (Engl). 2022;135(12):1414&#8211;24. 10.1097/CM9.0000000000002234.<pub-id pub-id-type="pmid">35940879</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CM9.0000000000002234</pub-id><pub-id pub-id-type="pmcid">PMC9481436</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rasheed</surname><given-names>H</given-names></name><name name-style="western"><surname>Walker</surname><given-names>V</given-names></name><name name-style="western"><surname>Sugawara</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Leng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Elsworth</surname><given-names>B</given-names></name><name name-style="western"><surname>Wootton</surname><given-names>RE</given-names></name><name name-style="western"><surname>Fang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease</article-title><source>Int J Epidemiol</source><year>2022</year><volume>50</volume><issue>6</issue><fpage>1995</fpage><lpage>2010</lpage><pub-id pub-id-type="doi">10.1093/ije/dyab203</pub-id><pub-id pub-id-type="pmid">34999880</pub-id><pub-id pub-id-type="pmcid">PMC8743120</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Zheng J, Zhang Y, Rasheed H, Walker V, Sugawara Y, Li J, Leng Y, Elsworth B, Wootton RE, Fang S, et al. Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease. Int J Epidemiol. 2022;50(6):1995&#8211;2010. 10.1093/ije/dyab203.<pub-id pub-id-type="pmid">34999880</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyab203</pub-id><pub-id pub-id-type="pmcid">PMC8743120</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hundemer</surname><given-names>GL</given-names></name><name name-style="western"><surname>Ravani</surname><given-names>P</given-names></name><name name-style="western"><surname>Sood</surname><given-names>MM</given-names></name><name name-style="western"><surname>Zimmerman</surname><given-names>D</given-names></name><name name-style="western"><surname>Molnar</surname><given-names>AO</given-names></name><name name-style="western"><surname>Moorman</surname><given-names>D</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>MJ</given-names></name><name name-style="western"><surname>White</surname><given-names>C</given-names></name><name name-style="western"><surname>Hiremath</surname><given-names>S</given-names></name><name name-style="western"><surname>Akbari</surname><given-names>A</given-names></name></person-group><article-title>Social determinants of health and the transition from advanced chronic kidney disease to kidney failure</article-title><source>Nephrol Dial Transplant</source><year>2023</year><volume>38</volume><issue>7</issue><fpage>1682</fpage><lpage>1690</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfac302</pub-id><pub-id pub-id-type="pmid">36316015</pub-id><pub-id pub-id-type="pmcid">PMC10310519</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Hundemer GL, Ravani P, Sood MM, Zimmerman D, Molnar AO, Moorman D, Oliver MJ, White C, Hiremath S, Akbari A. Social determinants of health and the transition from advanced chronic kidney disease to kidney failure. Nephrol Dial Transplant. 2023;38(7):1682&#8211;90. 10.1093/ndt/gfac302.<pub-id pub-id-type="pmid">36316015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ndt/gfac302</pub-id><pub-id pub-id-type="pmcid">PMC10310519</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crews</surname><given-names>DC</given-names></name><name name-style="western"><surname>McClellan</surname><given-names>WM</given-names></name><name name-style="western"><surname>Shoham</surname><given-names>DA</given-names></name><name name-style="western"><surname>Gao</surname><given-names>L</given-names></name><name name-style="western"><surname>Warnock</surname><given-names>DG</given-names></name><name name-style="western"><surname>Judd</surname><given-names>S</given-names></name><name name-style="western"><surname>Muntner</surname><given-names>P</given-names></name><name name-style="western"><surname>Miller</surname><given-names>ER</given-names></name><name name-style="western"><surname>Powe</surname><given-names>NR</given-names></name></person-group><article-title>Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants</article-title><source>Am J Kidney Dis</source><year>2012</year><volume>60</volume><issue>5</issue><fpage>779</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2012.05.010</pub-id><pub-id pub-id-type="pmid">22694949</pub-id><pub-id pub-id-type="pmcid">PMC3448844</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Crews DC, McClellan WM, Shoham DA, Gao L, Warnock DG, Judd S, Muntner P, Miller ER, Powe NR. Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants. Am J Kidney Dis. 2012;60(5):779&#8211;86. 10.1053/j.ajkd.2012.05.010.<pub-id pub-id-type="pmid">22694949</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.ajkd.2012.05.010</pub-id><pub-id pub-id-type="pmcid">PMC3448844</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caskey</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Roderick</surname><given-names>P</given-names></name><name name-style="western"><surname>Steenkamp</surname><given-names>R</given-names></name><name name-style="western"><surname>Nitsch</surname><given-names>D</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>K</given-names></name><name name-style="western"><surname>Ansell</surname><given-names>D</given-names></name><name name-style="western"><surname>Feest</surname><given-names>T</given-names></name></person-group><article-title>Social deprivation and survival on renal replacement therapy in England and Wales</article-title><source>Kidney Int</source><year>2006</year><volume>70</volume><issue>12</issue><fpage>2134</fpage><lpage>2140</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5001999</pub-id><pub-id pub-id-type="pmid">17063171</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Caskey FJ, Roderick P, Steenkamp R, Nitsch D, Thomas K, Ansell D, Feest T. Social deprivation and survival on renal replacement therapy in England and Wales. Kidney Int. 2006;70(12):2134&#8211;40. 10.1038/sj.ki.5001999.<pub-id pub-id-type="pmid">17063171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ki.5001999</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Said</surname><given-names>MA</given-names></name><name name-style="western"><surname>Verweij</surname><given-names>N</given-names></name><name name-style="western"><surname>van der Harst</surname><given-names>P</given-names></name></person-group><article-title>Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study</article-title><source>JAMA Cardiol</source><year>2018</year><volume>3</volume><issue>8</issue><fpage>693</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1001/jamacardio.2018.1717</pub-id><pub-id pub-id-type="pmid">29955826</pub-id><pub-id pub-id-type="pmcid">PMC6143077</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Said MA, Verweij N, van der Harst P. Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study. JAMA Cardiol. 2018;3(8):693&#8211;702. 10.1001/jamacardio.2018.1717.<pub-id pub-id-type="pmid">29955826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamacardio.2018.1717</pub-id><pub-id pub-id-type="pmcid">PMC6143077</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name><name name-style="western"><surname>Song</surname><given-names>H</given-names></name><name name-style="western"><surname>Fu</surname><given-names>P</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name></person-group><article-title>The association between patterns of exposure to adverse life events and the risk of chronic kidney disease: a prospective cohort study of 140,997 individuals</article-title><source>Transl Psychiatry</source><year>2024</year><volume>14</volume><issue>1</issue><fpage>424</fpage><pub-id pub-id-type="doi">10.1038/s41398-024-03114-4</pub-id><pub-id pub-id-type="pmid">39375339</pub-id><pub-id pub-id-type="pmcid">PMC11458756</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Li C, Chen J, Chen Y, Zhang C, Yang H, Yu S, Song H, Fu P, Zeng X. The association between patterns of exposure to adverse life events and the risk of chronic kidney disease: a prospective cohort study of 140,997 individuals. Transl Psychiatry. 2024;14(1):424. 10.1038/s41398-024-03114-4.<pub-id pub-id-type="pmid">39375339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41398-024-03114-4</pub-id><pub-id pub-id-type="pmcid">PMC11458756</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>TK</given-names></name><name name-style="western"><surname>Knicely</surname><given-names>DH</given-names></name><name name-style="western"><surname>Grams</surname><given-names>ME</given-names></name></person-group><article-title>Chronic Kidney Disease Diagnosis and Management: A Review</article-title><source>JAMA</source><year>2019</year><volume>322</volume><issue>13</issue><fpage>1294</fpage><lpage>1304</lpage><pub-id pub-id-type="doi">10.1001/jama.2019.14745</pub-id><pub-id pub-id-type="pmid">31573641</pub-id><pub-id pub-id-type="pmcid">PMC7015670</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019;322(13):1294&#8211;304. 10.1001/jama.2019.14745.<pub-id pub-id-type="pmid">31573641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2019.14745</pub-id><pub-id pub-id-type="pmcid">PMC7015670</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Navaneethan</surname><given-names>SD</given-names></name><name name-style="western"><surname>Zoungas</surname><given-names>S</given-names></name><name name-style="western"><surname>Caramori</surname><given-names>ML</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J</given-names></name><name name-style="western"><surname>Heerspink</surname><given-names>H</given-names></name><name name-style="western"><surname>Hurst</surname><given-names>C</given-names></name><name name-style="western"><surname>Liew</surname><given-names>A</given-names></name><name name-style="western"><surname>Michos</surname><given-names>ED</given-names></name><name name-style="western"><surname>Olowu</surname><given-names>WA</given-names></name><name name-style="western"><surname>Sadusky</surname><given-names>T</given-names></name><etal/></person-group><article-title>Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update</article-title><source>Ann Intern Med</source><year>2023</year><volume>176</volume><issue>3</issue><fpage>381</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.7326/M22-2904</pub-id><pub-id pub-id-type="pmid">36623286</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Navaneethan SD, Zoungas S, Caramori ML, Chan J, Heerspink H, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, et al. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Ann Intern Med. 2023;176(3):381&#8211;7. 10.7326/M22-2904.<pub-id pub-id-type="pmid">36623286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M22-2904</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colombo</surname><given-names>MG</given-names></name><name name-style="western"><surname>F&#246;rster</surname><given-names>C</given-names></name><name name-style="western"><surname>Wallwiener</surname><given-names>S</given-names></name><name name-style="western"><surname>Hassdenteufel</surname><given-names>K</given-names></name><name name-style="western"><surname>Hawighorst-Knapstein</surname><given-names>S</given-names></name><name name-style="western"><surname>Kirtschig</surname><given-names>G</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>A</given-names></name><name name-style="western"><surname>Dally</surname><given-names>S</given-names></name><name name-style="western"><surname>Joos</surname><given-names>S</given-names></name></person-group><article-title>Comorbidity, life-style factors and healthcare utilization in incident chronic kidney disease: sex-specific analyses of claims data</article-title><source>Nephrol Dial Transplant</source><year>2023</year><volume>38</volume><issue>3</issue><fpage>722</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfac245</pub-id><pub-id pub-id-type="pmid">35998324</pub-id><pub-id pub-id-type="pmcid">PMC9976763</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Colombo MG, F&#246;rster C, Wallwiener S, Hassdenteufel K, Hawighorst-Knapstein S, Kirtschig G, Chaudhuri A, Dally S, Joos S. Comorbidity, life-style factors and healthcare utilization in incident chronic kidney disease: sex-specific analyses of claims data. Nephrol Dial Transplant. 2023;38(3):722&#8211;32. 10.1093/ndt/gfac245.<pub-id pub-id-type="pmid">35998324</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ndt/gfac245</pub-id><pub-id pub-id-type="pmcid">PMC9976763</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>C</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ying</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gottfre&#240;sson</surname><given-names>M</given-names></name><etal/></person-group><article-title>COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank</article-title><source>BMC Med</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>301</fpage><pub-id pub-id-type="doi">10.1186/s12916-021-02177-0</pub-id><pub-id pub-id-type="pmid">34781951</pub-id><pub-id pub-id-type="pmcid">PMC8592806</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Hou C, Hu Y, Yang H, Chen W, Zeng Y, Ying Z, Hu Y, Sun Y, Qu Y, Gottfre&#240;sson M, et al. COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank. BMC Med. 2021;19(1):301. 10.1186/s12916-021-02177-0.<pub-id pub-id-type="pmid">34781951</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12916-021-02177-0</pub-id><pub-id pub-id-type="pmcid">PMC8592806</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quan</surname><given-names>H</given-names></name><name name-style="western"><surname>Sundararajan</surname><given-names>V</given-names></name><name name-style="western"><surname>Halfon</surname><given-names>P</given-names></name><name name-style="western"><surname>Fong</surname><given-names>A</given-names></name><name name-style="western"><surname>Burnand</surname><given-names>B</given-names></name><name name-style="western"><surname>Luthi</surname><given-names>JC</given-names></name><name name-style="western"><surname>Saunders</surname><given-names>LD</given-names></name><name name-style="western"><surname>Beck</surname><given-names>CA</given-names></name><name name-style="western"><surname>Feasby</surname><given-names>TE</given-names></name><name name-style="western"><surname>Ghali</surname><given-names>WA</given-names></name></person-group><article-title>Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data</article-title><source>Med Care</source><year>2005</year><volume>43</volume><issue>11</issue><fpage>1130</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1097/01.mlr.0000182534.19832.83</pub-id><pub-id pub-id-type="pmid">16224307</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130&#8211;9. 10.1097/01.mlr.0000182534.19832.83.<pub-id pub-id-type="pmid">16224307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.mlr.0000182534.19832.83</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>S</given-names></name><name name-style="western"><surname>Koyama</surname><given-names>S</given-names></name><name name-style="western"><surname>Honigberg</surname><given-names>MC</given-names></name><name name-style="western"><surname>Surakka</surname><given-names>I</given-names></name><name name-style="western"><surname>Haidermota</surname><given-names>S</given-names></name><name name-style="western"><surname>Ganesh</surname><given-names>S</given-names></name><name name-style="western"><surname>Patel</surname><given-names>AP</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>R</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study</article-title><source>Eur Heart J</source><year>2023</year><volume>44</volume><issue>36</issue><fpage>3456</fpage><lpage>3465</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehad380</pub-id><pub-id pub-id-type="pmid">37350734</pub-id><pub-id pub-id-type="pmcid">PMC10516626</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Cho S, Koyama S, Honigberg MC, Surakka I, Haidermota S, Ganesh S, Patel AP, Bhattacharya R, Lee H, Kim HC, et al. Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study. Eur Heart J. 2023;44(36):3456&#8211;65. 10.1093/eurheartj/ehad380.<pub-id pub-id-type="pmid">37350734</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehad380</pub-id><pub-id pub-id-type="pmcid">PMC10516626</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Tang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ying</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Fu</surname><given-names>P</given-names></name><name name-style="western"><surname>Song</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><etal/></person-group><article-title>Genetic impact on the association of sleep patterns and chronic kidney disease: A prospective cohort study of 157,175 UK Biobank participants</article-title><source>J Psychosom Res</source><year>2023</year><volume>169</volume><fpage>111323</fpage><pub-id pub-id-type="doi">10.1016/j.jpsychores.2023.111323</pub-id><pub-id pub-id-type="pmid">37037154</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Li C, Chen Y, Zhao W, Zhang C, Tang L, Ying Z, Chen W, Fu P, Song H, Zhou X, et al. Genetic impact on the association of sleep patterns and chronic kidney disease: A prospective cohort study of 157,175 UK Biobank participants. J Psychosom Res. 2023;169:111323. 10.1016/j.jpsychores.2023.111323.<pub-id pub-id-type="pmid">37037154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychores.2023.111323</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuttke</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Sieber</surname><given-names>KB</given-names></name><name name-style="western"><surname>Feitosa</surname><given-names>MF</given-names></name><name name-style="western"><surname>Gorski</surname><given-names>M</given-names></name><name name-style="western"><surname>Tin</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Chu</surname><given-names>AY</given-names></name><name name-style="western"><surname>Hoppmann</surname><given-names>A</given-names></name><etal/></person-group><article-title>A catalog of genetic loci associated with kidney function from analyses of a million individuals</article-title><source>Nat Genet</source><year>2019</year><volume>51</volume><issue>6</issue><fpage>957</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0407-x</pub-id><pub-id pub-id-type="pmid">31152163</pub-id><pub-id pub-id-type="pmcid">PMC6698888</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, Tin A, Wang L, Chu AY, Hoppmann A, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019;51(6):957&#8211;72. 10.1038/s41588-019-0407-x.<pub-id pub-id-type="pmid">31152163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-019-0407-x</pub-id><pub-id pub-id-type="pmcid">PMC6698888</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuitunen</surname><given-names>I</given-names></name><name name-style="western"><surname>Ponkilainen</surname><given-names>VT</given-names></name><name name-style="western"><surname>Uimonen</surname><given-names>MM</given-names></name><name name-style="western"><surname>Eskelinen</surname><given-names>A</given-names></name><name name-style="western"><surname>Reito</surname><given-names>A</given-names></name></person-group><article-title>Testing the proportional hazards assumption in cox regression and dealing with possible non-proportionality in total joint arthroplasty research: methodological perspectives and review</article-title><source>BMC Musculoskelet Disord</source><year>2021</year><volume>22</volume><issue>1</issue><fpage>489</fpage><pub-id pub-id-type="doi">10.1186/s12891-021-04379-2</pub-id><pub-id pub-id-type="pmid">34049528</pub-id><pub-id pub-id-type="pmcid">PMC8161573</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Kuitunen I, Ponkilainen VT, Uimonen MM, Eskelinen A, Reito A. Testing the proportional hazards assumption in cox regression and dealing with possible non-proportionality in total joint arthroplasty research: methodological perspectives and review. BMC Musculoskelet Disord. 2021;22(1):489. 10.1186/s12891-021-04379-2.<pub-id pub-id-type="pmid">34049528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12891-021-04379-2</pub-id><pub-id pub-id-type="pmcid">PMC8161573</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vyas</surname><given-names>MV</given-names></name><name name-style="western"><surname>Fang</surname><given-names>J</given-names></name><name name-style="western"><surname>Kapral</surname><given-names>MK</given-names></name><name name-style="western"><surname>Austin</surname><given-names>PC</given-names></name></person-group><article-title>Choice of time-scale in time-to-event analysis: evaluating age-dependent associations</article-title><source>Ann Epidemiol</source><year>2021</year><volume>62</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.annepidem.2021.06.006</pub-id><pub-id pub-id-type="pmid">34174410</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Vyas MV, Fang J, Kapral MK, Austin PC. Choice of time-scale in time-to-event analysis: evaluating age-dependent associations. Ann Epidemiol. 2021;62:69&#8211;76. 10.1016/j.annepidem.2021.06.006.<pub-id pub-id-type="pmid">34174410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.annepidem.2021.06.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>PC</given-names></name><name name-style="western"><surname>Royston</surname><given-names>P</given-names></name></person-group><article-title>Further development of flexible parametric models for survival analysis</article-title><source>Stata Journal</source><year>2009</year><volume>9</volume><issue>2</issue><fpage>265</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1007/978-3-7643-8799-0_6</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata Journal. 2009;9(2):265&#8211;90. 10.1007/978-3-7643-8799-0_6.</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Organization WH. A healthy lifestyle - WHO recommendations. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations">https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations</ext-link>.</mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Tingley D, Teppei H, Mit Y, Keele L, Imai K. Mediation: R Package for Causal Mediation Analysis. J Stat Software. 2014;59(5). 10.18637/jss.v059.i05.</mixed-citation></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoertel</surname><given-names>N</given-names></name><name name-style="western"><surname>McMahon</surname><given-names>K</given-names></name><name name-style="western"><surname>Olfson</surname><given-names>M</given-names></name><name name-style="western"><surname>Wall</surname><given-names>MM</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Fern&#225;ndez</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lemogne</surname><given-names>C</given-names></name><name name-style="western"><surname>Limosin</surname><given-names>F</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>C</given-names></name></person-group><article-title>A dimensional liability model of age differences in mental disorder prevalence: evidence from a national sample</article-title><source>J Psychiatr Res</source><year>2015</year><volume>64</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2015.03.017</pub-id><pub-id pub-id-type="pmid">25858414</pub-id><pub-id pub-id-type="pmcid">PMC4404219</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Hoertel N, McMahon K, Olfson M, Wall MM, Rodr&#237;guez-Fern&#225;ndez JM, Lemogne C, Limosin F, Blanco C. A dimensional liability model of age differences in mental disorder prevalence: evidence from a national sample. J Psychiatr Res. 2015;64:107&#8211;13. 10.1016/j.jpsychires.2015.03.017.<pub-id pub-id-type="pmid">25858414</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2015.03.017</pub-id><pub-id pub-id-type="pmcid">PMC4404219</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussain</surname><given-names>J</given-names></name><name name-style="western"><surname>Grubic</surname><given-names>N</given-names></name><name name-style="western"><surname>Akbari</surname><given-names>A</given-names></name><name name-style="western"><surname>Canney</surname><given-names>M</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ravani</surname><given-names>P</given-names></name><name name-style="western"><surname>Tanuseputro</surname><given-names>P</given-names></name><name name-style="western"><surname>Clark</surname><given-names>EG</given-names></name><name name-style="western"><surname>Hundemer</surname><given-names>GL</given-names></name><name name-style="western"><surname>Ramsay</surname><given-names>T</given-names></name><etal/></person-group><article-title>Associations between modest reductions in kidney function and adverse outcomes in young adults: retrospective, population based cohort study</article-title><source>BMJ.</source><year>2023</year><volume>381</volume><fpage>e075062</fpage><pub-id pub-id-type="doi">10.1136/bmj-2023-075062</pub-id><pub-id pub-id-type="pmid">37353230</pub-id><pub-id pub-id-type="pmcid">PMC10286512</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Hussain J, Grubic N, Akbari A, Canney M, Elliott MJ, Ravani P, Tanuseputro P, Clark EG, Hundemer GL, Ramsay T, et al. Associations between modest reductions in kidney function and adverse outcomes in young adults: retrospective, population based cohort study. BMJ. 2023;381:e075062. 10.1136/bmj-2023-075062.<pub-id pub-id-type="pmid">37353230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2023-075062</pub-id><pub-id pub-id-type="pmcid">PMC10286512</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bowe</surname><given-names>B</given-names></name><name name-style="western"><surname>Mokdad</surname><given-names>AH</given-names></name><name name-style="western"><surname>Xian</surname><given-names>H</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Maddukuri</surname><given-names>G</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>CY</given-names></name><name name-style="western"><surname>Floyd</surname><given-names>T</given-names></name><name name-style="western"><surname>Al-Aly</surname><given-names>Z</given-names></name></person-group><article-title>Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016</article-title><source>Kidney Int</source><year>2018</year><volume>94</volume><issue>3</issue><fpage>567</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2018.04.011</pub-id><pub-id pub-id-type="pmid">30078514</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, Maddukuri G, Tsai CY, Floyd T, Al-Aly Z. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567&#8211;81. 10.1016/j.kint.2018.04.011.<pub-id pub-id-type="pmid">30078514</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.kint.2018.04.011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nangaku</surname><given-names>M</given-names></name><name name-style="western"><surname>Yanagita</surname><given-names>M</given-names></name></person-group><article-title>Aging-Related Kidney Diseases</article-title><source>Contrib Nephrol</source><year>2021</year><volume>199</volume><fpage>266</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1159/000517708</pub-id><pub-id pub-id-type="pmid">34343996</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Kitai Y, Nangaku M, Yanagita M. Aging-Related Kidney Diseases. Contrib Nephrol. 2021;199:266&#8211;73. 10.1159/000517708.<pub-id pub-id-type="pmid">34343996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000517708</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gold</surname><given-names>PW</given-names></name></person-group><article-title>The organization of the stress system and its dysregulation in depressive illness</article-title><source>Mol Psychiatry</source><year>2015</year><volume>20</volume><issue>1</issue><fpage>32</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1038/mp.2014.163</pub-id><pub-id pub-id-type="pmid">25486982</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Gold PW. The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry. 2015;20(1):32&#8211;47. 10.1038/mp.2014.163.<pub-id pub-id-type="pmid">25486982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2014.163</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>R&#233;v&#233;sz</surname><given-names>D</given-names></name><name name-style="western"><surname>Verhoeven</surname><given-names>JE</given-names></name><name name-style="western"><surname>Milaneschi</surname><given-names>Y</given-names></name><name name-style="western"><surname>de Geus</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Wolkowitz</surname><given-names>OM</given-names></name><name name-style="western"><surname>Penninx</surname><given-names>BW</given-names></name></person-group><article-title>Dysregulated physiological stress systems and accelerated cellular aging</article-title><source>Neurobiol Aging</source><year>2014</year><volume>35</volume><issue>6</issue><fpage>1422</fpage><lpage>1430</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.12.027</pub-id><pub-id pub-id-type="pmid">24439483</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">R&#233;v&#233;sz D, Verhoeven JE, Milaneschi Y, de Geus EJ, Wolkowitz OM, Penninx BW. Dysregulated physiological stress systems and accelerated cellular aging. Neurobiol Aging. 2014;35(6):1422&#8211;30. 10.1016/j.neurobiolaging.2013.12.027.<pub-id pub-id-type="pmid">24439483</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neurobiolaging.2013.12.027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kivim&#228;ki</surname><given-names>M</given-names></name><name name-style="western"><surname>Steptoe</surname><given-names>A</given-names></name></person-group><article-title>Effects of stress on the development and progression of cardiovascular disease</article-title><source>Nat Rev Cardiol</source><year>2018</year><volume>15</volume><issue>4</issue><fpage>215</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2017.189</pub-id><pub-id pub-id-type="pmid">29213140</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Kivim&#228;ki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol. 2018;15(4):215&#8211;29. 10.1038/nrcardio.2017.189.<pub-id pub-id-type="pmid">29213140</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrcardio.2017.189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fr&#261;k</surname><given-names>W</given-names></name><name name-style="western"><surname>Ku&#263;mierz</surname><given-names>J</given-names></name><name name-style="western"><surname>Szlagor</surname><given-names>M</given-names></name><name name-style="western"><surname>M&#322;ynarska</surname><given-names>E</given-names></name><name name-style="western"><surname>Rysz</surname><given-names>J</given-names></name><name name-style="western"><surname>Franczyk</surname><given-names>B</given-names></name></person-group><article-title>New Insights into Molecular Mechanisms of Chronic Kidney Disease</article-title><source>Biomedicines</source><year>2022</year><volume>10</volume><issue>11</issue><fpage>2846</fpage><pub-id pub-id-type="doi">10.3390/biomedicines10112846</pub-id><pub-id pub-id-type="pmid">36359366</pub-id><pub-id pub-id-type="pmcid">PMC9687691</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Fr&#261;k W, Ku&#263;mierz J, Szlagor M, M&#322;ynarska E, Rysz J, Franczyk B. New Insights into Molecular Mechanisms of Chronic Kidney Disease. Biomedicines. 2022;10(11):2846. 10.3390/biomedicines10112846.<pub-id pub-id-type="pmid">36359366</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biomedicines10112846</pub-id><pub-id pub-id-type="pmcid">PMC9687691</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whaley-Connell</surname><given-names>A</given-names></name><name name-style="western"><surname>Nistala</surname><given-names>R</given-names></name><name name-style="western"><surname>Chaudhary</surname><given-names>K</given-names></name></person-group><article-title>The importance of early identification of chronic kidney disease</article-title><source>Mo Med</source><year>2011</year><volume>108</volume><issue>1</issue><fpage>25</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">21462606</pub-id><pub-id pub-id-type="pmcid">PMC6188457</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Whaley-Connell A, Nistala R, Chaudhary K. The importance of early identification of chronic kidney disease. Mo Med. 2011;108(1):25&#8211;8.<pub-id pub-id-type="pmid">21462606</pub-id><pub-id pub-id-type="pmcid">PMC6188457</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burnier</surname><given-names>M</given-names></name><name name-style="western"><surname>Damianaki</surname><given-names>A</given-names></name></person-group><article-title>Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease</article-title><source>Circ Res</source><year>2023</year><volume>132</volume><issue>8</issue><fpage>1050</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.122.321762</pub-id><pub-id pub-id-type="pmid">37053276</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Burnier M, Damianaki A. Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease. Circ Res. 2023;132(8):1050&#8211;63. 10.1161/CIRCRESAHA.122.321762.<pub-id pub-id-type="pmid">37053276</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.122.321762</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindekilde</surname><given-names>N</given-names></name><name name-style="western"><surname>Scheuer</surname><given-names>SH</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>KH</given-names></name><name name-style="western"><surname>Plana-Ripoll</surname><given-names>O</given-names></name><name name-style="western"><surname>Henriksen</surname><given-names>JE</given-names></name><name name-style="western"><surname>Lasgaard</surname><given-names>M</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>GS</given-names></name><name name-style="western"><surname>Pouwer</surname><given-names>F</given-names></name></person-group><article-title>Risk of Developing Type 2 Diabetes in Individuals With a Psychiatric Disorder: A Nationwide Register-Based Cohort Study</article-title><source>Diabetes Care</source><year>2022</year><volume>45</volume><issue>3</issue><fpage>724</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.2337/dc21-1864</pub-id><pub-id pub-id-type="pmid">35043146</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Lindekilde N, Scheuer SH, Diaz LJ, Rubin KH, Plana-Ripoll O, Henriksen JE, Lasgaard M, Andersen GS, Pouwer F. Risk of Developing Type 2 Diabetes in Individuals With a Psychiatric Disorder: A Nationwide Register-Based Cohort Study. Diabetes Care. 2022;45(3):724&#8211;33. 10.2337/dc21-1864.<pub-id pub-id-type="pmid">35043146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc21-1864</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindekilde</surname><given-names>N</given-names></name><name name-style="western"><surname>Rutters</surname><given-names>F</given-names></name><name name-style="western"><surname>Erik Henriksen</surname><given-names>J</given-names></name><name name-style="western"><surname>Lasgaard</surname><given-names>M</given-names></name><name name-style="western"><surname>Schram</surname><given-names>MT</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>KH</given-names></name><name name-style="western"><surname>Kivim&#228;ki</surname><given-names>M</given-names></name><name name-style="western"><surname>Nefs</surname><given-names>G</given-names></name><name name-style="western"><surname>Pouwer</surname><given-names>F</given-names></name></person-group><article-title>Psychiatric disorders as risk factors for type 2 diabetes: An umbrella review of systematic reviews with and without meta-analyses</article-title><source>Diabetes Res Clin Pract</source><year>2021</year><volume>176</volume><fpage>108855</fpage><pub-id pub-id-type="doi">10.1016/j.diabres.2021.108855</pub-id><pub-id pub-id-type="pmid">33965448</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Lindekilde N, Rutters F, Erik Henriksen J, Lasgaard M, Schram MT, Rubin KH, Kivim&#228;ki M, Nefs G, Pouwer F. Psychiatric disorders as risk factors for type 2 diabetes: An umbrella review of systematic reviews with and without meta-analyses. Diabetes Res Clin Pract. 2021;176:108855. 10.1016/j.diabres.2021.108855.<pub-id pub-id-type="pmid">33965448</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.diabres.2021.108855</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dabbas</surname><given-names>W</given-names></name><name name-style="western"><surname>Gangemi</surname><given-names>A</given-names></name><name name-style="western"><surname>Benedetti</surname><given-names>E</given-names></name><name name-style="western"><surname>Lash</surname><given-names>J</given-names></name><name name-style="western"><surname>Finn</surname><given-names>PW</given-names></name><name name-style="western"><surname>Perkins</surname><given-names>DL</given-names></name></person-group><article-title>Obesity Management and Chronic Kidney Disease</article-title><source>Semin Nephrol</source><year>2021</year><volume>41</volume><issue>4</issue><fpage>392</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.semnephrol.2021.06.010</pub-id><pub-id pub-id-type="pmid">34715968</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Chen Y, Dabbas W, Gangemi A, Benedetti E, Lash J, Finn PW, Perkins DL. Obesity Management and Chronic Kidney Disease. Semin Nephrol. 2021;41(4):392&#8211;402. 10.1016/j.semnephrol.2021.06.010.<pub-id pub-id-type="pmid">34715968</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semnephrol.2021.06.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>RZ</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Deng</surname><given-names>YT</given-names></name><name name-style="western"><surname>Wang</surname><given-names>HF</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Feng</surname><given-names>JF</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>W</given-names></name><name name-style="western"><surname>Yu</surname><given-names>JT</given-names></name></person-group><article-title>Body weight in neurological and psychiatric disorders: a large prospective cohort study</article-title><source>Nature Mental Health</source><year>2024</year><volume>2</volume><issue>1</issue><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/s44220-023-00158-1</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Wang RZ, He Y, Deng YT, Wang HF, Zhang Y, Feng JF, Cheng W, Yu JT. Body weight in neurological and psychiatric disorders: a large prospective cohort study. Nature Mental Health. 2024;2(1):41&#8211;51. 10.1038/s44220-023-00158-1.</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yau</surname><given-names>K</given-names></name><name name-style="western"><surname>Kuah</surname><given-names>R</given-names></name><name name-style="western"><surname>Cherney</surname><given-names>D</given-names></name><name name-style="western"><surname>Lam</surname><given-names>T</given-names></name></person-group><article-title>Obesity and the kidney: mechanistic links and therapeutic advances</article-title><source>Nat Rev Endocrinol</source><year>2024</year><volume>20</volume><issue>6</issue><fpage>321</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1038/s41574-024-00951-7</pub-id><pub-id pub-id-type="pmid">38351406</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Yau K, Kuah R, Cherney D, Lam T. Obesity and the kidney: mechanistic links and therapeutic advances. Nat Rev Endocrinol. 2024;20(6):321&#8211;35. 10.1038/s41574-024-00951-7.<pub-id pub-id-type="pmid">38351406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41574-024-00951-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>JE</given-names></name><name name-style="western"><surname>Mouton</surname><given-names>AJ</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>AA</given-names></name><name name-style="western"><surname>Omoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>do Carmo</surname><given-names>JM</given-names></name></person-group><article-title>Obesity, kidney dysfunction, and inflammation: interactions in hypertension</article-title><source>Cardiovasc Res.</source><year>2021</year><volume>117</volume><issue>8</issue><fpage>1859</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvaa336</pub-id><pub-id pub-id-type="pmid">33258945</pub-id><pub-id pub-id-type="pmcid">PMC8262632</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Hall JE, Mouton AJ, da Silva AA, Omoto A, Wang Z, Li X, do Carmo JM. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021;117(8):1859&#8211;76. 10.1093/cvr/cvaa336.<pub-id pub-id-type="pmid">33258945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cvr/cvaa336</pub-id><pub-id pub-id-type="pmcid">PMC8262632</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brennan</surname><given-names>E</given-names></name><name name-style="western"><surname>Kantharidis</surname><given-names>P</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>ME</given-names></name><name name-style="western"><surname>Godson</surname><given-names>C</given-names></name></person-group><article-title>Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function</article-title><source>Nat Rev Nephrol</source><year>2021</year><volume>17</volume><issue>11</issue><fpage>725</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1038/s41581-021-00454-y</pub-id><pub-id pub-id-type="pmid">34282342</pub-id><pub-id pub-id-type="pmcid">PMC8287849</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Brennan E, Kantharidis P, Cooper ME, Godson C. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol. 2021;17(11):725&#8211;39. 10.1038/s41581-021-00454-y.<pub-id pub-id-type="pmid">34282342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41581-021-00454-y</pub-id><pub-id pub-id-type="pmcid">PMC8287849</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Sloten</surname><given-names>TT</given-names></name><name name-style="western"><surname>Sedaghat</surname><given-names>S</given-names></name><name name-style="western"><surname>Carnethon</surname><given-names>MR</given-names></name><name name-style="western"><surname>Launer</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Stehouwer</surname><given-names>C</given-names></name></person-group><article-title>Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression</article-title><source>Lancet Diab Endocrinol</source><year>2020</year><volume>8</volume><issue>4</issue><fpage>325</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(19)30405-X</pub-id><pub-id pub-id-type="pmcid">PMC11044807</pub-id><pub-id pub-id-type="pmid">32135131</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer C. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diab Endocrinol. 2020;8(4):325&#8211;36. 10.1016/S2213-8587(19)30405-X.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-8587(19)30405-X</pub-id><pub-id pub-id-type="pmcid">PMC11044807</pub-id><pub-id pub-id-type="pmid">32135131</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shirazian</surname><given-names>S</given-names></name><name name-style="western"><surname>Grant</surname><given-names>CD</given-names></name><name name-style="western"><surname>Aina</surname><given-names>O</given-names></name><name name-style="western"><surname>Mattana</surname><given-names>J</given-names></name><name name-style="western"><surname>Khorassani</surname><given-names>F</given-names></name><name name-style="western"><surname>Ricardo</surname><given-names>AC</given-names></name></person-group><article-title>Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management</article-title><source>Kidney Int Rep</source><year>2017</year><volume>2</volume><issue>1</issue><fpage>94</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.ekir.2016.09.005</pub-id><pub-id pub-id-type="pmid">29318209</pub-id><pub-id pub-id-type="pmcid">PMC5720531</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Shirazian S, Grant CD, Aina O, Mattana J, Khorassani F, Ricardo AC. Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management. Kidney Int Rep. 2017;2(1):94&#8211;107. 10.1016/j.ekir.2016.09.005.<pub-id pub-id-type="pmid">29318209</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ekir.2016.09.005</pub-id><pub-id pub-id-type="pmcid">PMC5720531</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>He</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Association of Depressive Symptoms with Rapid Kidney Function Decline in Adults with Normal Kidney Function</article-title><source>Clin J Am Soc Nephrol</source><year>2021</year><volume>16</volume><issue>6</issue><fpage>889</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.2215/CJN.18441120</pub-id><pub-id pub-id-type="pmid">34052796</pub-id><pub-id pub-id-type="pmcid">PMC8216614</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Zhang Z, He P, Liu M, Zhou C, Liu C, Li H, Zhang Y, Li Q, Ye Z, Wu Q, et al. Association of Depressive Symptoms with Rapid Kidney Function Decline in Adults with Normal Kidney Function. Clin J Am Soc Nephrol. 2021;16(6):889&#8211;97. 10.2215/CJN.18441120.<pub-id pub-id-type="pmid">34052796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2215/CJN.18441120</pub-id><pub-id pub-id-type="pmcid">PMC8216614</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kang</surname><given-names>MW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YC</given-names></name><name name-style="western"><surname>Han</surname><given-names>SS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Causal Effects of Positive Affect, Life Satisfaction, Depressive Symptoms, and Neuroticism on Kidney Function: A Mendelian Randomization Study</article-title><source>J Am Soc Nephrol</source><year>2021</year><volume>32</volume><issue>6</issue><fpage>1484</fpage><lpage>1496</lpage><pub-id pub-id-type="doi">10.1681/ASN.2020071086</pub-id><pub-id pub-id-type="pmid">33785582</pub-id><pub-id pub-id-type="pmcid">PMC8259638</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Park S, Lee S, Kim Y, Lee Y, Kang MW, Kim K, Kim YC, Han SS, Lee H, Lee JP, et al. Causal Effects of Positive Affect, Life Satisfaction, Depressive Symptoms, and Neuroticism on Kidney Function: A Mendelian Randomization Study. J Am Soc Nephrol. 2021;32(6):1484&#8211;96. 10.1681/ASN.2020071086.<pub-id pub-id-type="pmid">33785582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1681/ASN.2020071086</pub-id><pub-id pub-id-type="pmcid">PMC8259638</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Mao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>T</given-names></name></person-group><article-title>Association of anxiety, depression symptoms and sleep quality with chronic kidney disease among older Chinese</article-title><source>Medicine (Baltimore).</source><year>2023</year><volume>102</volume><issue>43</issue><fpage>e35812</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000035812</pub-id><pub-id pub-id-type="pmid">37904348</pub-id><pub-id pub-id-type="pmcid">PMC10615427</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Huang J, Mao Y, Zhao X, Liu Q, Zheng T. Association of anxiety, depression symptoms and sleep quality with chronic kidney disease among older Chinese. Medicine (Baltimore). 2023;102(43):e35812. 10.1097/MD.0000000000035812.<pub-id pub-id-type="pmid">37904348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000035812</pub-id><pub-id pub-id-type="pmcid">PMC10615427</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>JP</given-names></name><name name-style="western"><surname>Carmo</surname><given-names>H</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>F</given-names></name></person-group><article-title>Drugs of abuse and kidney toxicity</article-title><source>Current Opinion in Toxicology</source><year>2022</year><pub-id pub-id-type="doi">10.1016/j.cotox.2022.100360</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Silva JP, Carmo H, Carvalho F. Drugs of abuse and kidney toxicity. Current Opinion in Toxicology. 2022. 10.1016/j.cotox.2022.100360.</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tzur Bitan</surname><given-names>D</given-names></name><name name-style="western"><surname>Krieger</surname><given-names>I</given-names></name><name name-style="western"><surname>Berkovitch</surname><given-names>A</given-names></name><name name-style="western"><surname>Comaneshter</surname><given-names>D</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>A</given-names></name></person-group><article-title>Chronic kidney disease in adults with schizophrenia: A nationwide population-based study</article-title><source>Gen Hosp Psychiatry</source><year>2019</year><volume>58</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2019.01.007</pub-id><pub-id pub-id-type="pmid">30807892</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Tzur Bitan D, Krieger I, Berkovitch A, Comaneshter D, Cohen A. Chronic kidney disease in adults with schizophrenia: A nationwide population-based study. Gen Hosp Psychiatry. 2019;58:1&#8211;6. 10.1016/j.genhosppsych.2019.01.007.<pub-id pub-id-type="pmid">30807892</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.genhosppsych.2019.01.007</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>